JP2012524279A - 診断デバイスおよび関連する方法 - Google Patents
診断デバイスおよび関連する方法 Download PDFInfo
- Publication number
- JP2012524279A JP2012524279A JP2012506190A JP2012506190A JP2012524279A JP 2012524279 A JP2012524279 A JP 2012524279A JP 2012506190 A JP2012506190 A JP 2012506190A JP 2012506190 A JP2012506190 A JP 2012506190A JP 2012524279 A JP2012524279 A JP 2012524279A
- Authority
- JP
- Japan
- Prior art keywords
- analyte
- test strip
- sample
- laser
- diagnostic system
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 238000000034 method Methods 0.000 title claims abstract description 144
- 239000012491 analyte Substances 0.000 claims abstract description 442
- 238000012360 testing method Methods 0.000 claims abstract description 410
- 238000001514 detection method Methods 0.000 claims abstract description 158
- 239000003795 chemical substances by application Substances 0.000 claims abstract description 155
- 239000000758 substrate Substances 0.000 claims abstract description 61
- 238000000576 coating method Methods 0.000 claims abstract description 47
- 239000011248 coating agent Substances 0.000 claims abstract description 46
- 239000011230 binding agent Substances 0.000 claims description 62
- 230000027455 binding Effects 0.000 claims description 39
- 239000000020 Nitrocellulose Substances 0.000 claims description 38
- 239000003550 marker Substances 0.000 claims description 38
- 239000000463 material Substances 0.000 claims description 38
- 229920001220 nitrocellulos Polymers 0.000 claims description 38
- 238000004458 analytical method Methods 0.000 claims description 26
- 230000035945 sensitivity Effects 0.000 claims description 20
- 239000000203 mixture Substances 0.000 claims description 18
- 239000000427 antigen Substances 0.000 claims description 17
- 108091007433 antigens Proteins 0.000 claims description 17
- 102000036639 antigens Human genes 0.000 claims description 17
- 239000000835 fiber Substances 0.000 claims description 16
- 238000004519 manufacturing process Methods 0.000 claims description 14
- 210000004369 blood Anatomy 0.000 claims description 13
- 239000008280 blood Substances 0.000 claims description 13
- 238000000695 excitation spectrum Methods 0.000 claims description 9
- 102000035118 modified proteins Human genes 0.000 claims description 8
- 108091005573 modified proteins Proteins 0.000 claims description 8
- 108090000765 processed proteins & peptides Proteins 0.000 claims description 8
- 238000001228 spectrum Methods 0.000 claims description 8
- 239000003446 ligand Substances 0.000 claims description 7
- 239000008241 heterogeneous mixture Substances 0.000 claims description 6
- 239000006166 lysate Substances 0.000 claims description 6
- 108020003175 receptors Proteins 0.000 claims description 6
- 230000001678 irradiating effect Effects 0.000 claims description 3
- 238000012549 training Methods 0.000 claims description 2
- 239000000523 sample Substances 0.000 description 314
- 230000003287 optical effect Effects 0.000 description 168
- 230000005284 excitation Effects 0.000 description 129
- 239000012530 fluid Substances 0.000 description 93
- 238000003556 assay Methods 0.000 description 66
- 230000033001 locomotion Effects 0.000 description 41
- 230000007246 mechanism Effects 0.000 description 37
- 238000012986 modification Methods 0.000 description 35
- 230000004048 modification Effects 0.000 description 35
- YBJHBAHKTGYVGT-ZKWXMUAHSA-N (+)-Biotin Chemical compound N1C(=O)N[C@@H]2[C@H](CCCCC(=O)O)SC[C@@H]21 YBJHBAHKTGYVGT-ZKWXMUAHSA-N 0.000 description 30
- 238000000295 emission spectrum Methods 0.000 description 28
- 239000002585 base Substances 0.000 description 27
- 239000011521 glass Substances 0.000 description 26
- 101100537532 Rattus norvegicus Tnni3 gene Proteins 0.000 description 23
- 238000011534 incubation Methods 0.000 description 22
- 108010090804 Streptavidin Proteins 0.000 description 19
- 238000010438 heat treatment Methods 0.000 description 18
- 238000005259 measurement Methods 0.000 description 18
- 230000003595 spectral effect Effects 0.000 description 18
- 229960002685 biotin Drugs 0.000 description 15
- 235000020958 biotin Nutrition 0.000 description 15
- 239000011616 biotin Substances 0.000 description 15
- 238000001816 cooling Methods 0.000 description 15
- 241000283973 Oryctolagus cuniculus Species 0.000 description 14
- 238000004891 communication Methods 0.000 description 14
- 238000003860 storage Methods 0.000 description 14
- 230000008859 change Effects 0.000 description 13
- 239000000872 buffer Substances 0.000 description 12
- 239000013256 coordination polymer Substances 0.000 description 12
- 230000006870 function Effects 0.000 description 12
- 239000000126 substance Substances 0.000 description 12
- IAZDPXIOMUYVGZ-UHFFFAOYSA-N Dimethylsulphoxide Chemical compound CS(C)=O IAZDPXIOMUYVGZ-UHFFFAOYSA-N 0.000 description 11
- 239000012888 bovine serum Substances 0.000 description 11
- 108091003079 Bovine Serum Albumin Proteins 0.000 description 10
- 239000000853 adhesive Substances 0.000 description 10
- 230000001070 adhesive effect Effects 0.000 description 10
- 229940098773 bovine serum albumin Drugs 0.000 description 10
- 230000002745 absorbent Effects 0.000 description 9
- 239000002250 absorbent Substances 0.000 description 9
- 230000005540 biological transmission Effects 0.000 description 9
- 239000000243 solution Substances 0.000 description 9
- HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 description 8
- 238000013461 design Methods 0.000 description 8
- 238000012545 processing Methods 0.000 description 8
- 235000018102 proteins Nutrition 0.000 description 8
- 102000004169 proteins and genes Human genes 0.000 description 8
- 108090000623 proteins and genes Proteins 0.000 description 8
- 239000012528 membrane Substances 0.000 description 7
- 108020004707 nucleic acids Proteins 0.000 description 7
- 102000039446 nucleic acids Human genes 0.000 description 7
- 150000007523 nucleic acids Chemical class 0.000 description 7
- 102400001263 NT-proBNP Human genes 0.000 description 6
- 238000000149 argon plasma sintering Methods 0.000 description 6
- 238000005266 casting Methods 0.000 description 6
- 238000010586 diagram Methods 0.000 description 6
- 230000000694 effects Effects 0.000 description 6
- 239000013307 optical fiber Substances 0.000 description 6
- 108010008064 pro-brain natriuretic peptide (1-76) Proteins 0.000 description 6
- 230000002829 reductive effect Effects 0.000 description 6
- 230000004044 response Effects 0.000 description 6
- 238000011282 treatment Methods 0.000 description 6
- AZUYLZMQTIKGSC-UHFFFAOYSA-N 1-[6-[4-(5-chloro-6-methyl-1H-indazol-4-yl)-5-methyl-3-(1-methylindazol-5-yl)pyrazol-1-yl]-2-azaspiro[3.3]heptan-2-yl]prop-2-en-1-one Chemical compound ClC=1C(=C2C=NNC2=CC=1C)C=1C(=NN(C=1C)C1CC2(CN(C2)C(C=C)=O)C1)C=1C=C2C=NN(C2=CC=1)C AZUYLZMQTIKGSC-UHFFFAOYSA-N 0.000 description 5
- 239000003154 D dimer Substances 0.000 description 5
- 239000013584 assay control Substances 0.000 description 5
- 150000001875 compounds Chemical class 0.000 description 5
- 201000010099 disease Diseases 0.000 description 5
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 5
- 230000036541 health Effects 0.000 description 5
- 239000011550 stock solution Substances 0.000 description 5
- 230000009471 action Effects 0.000 description 4
- 230000004913 activation Effects 0.000 description 4
- -1 control Substances 0.000 description 4
- DDRJAANPRJIHGJ-UHFFFAOYSA-N creatinine Chemical compound CN1CC(=O)NC1=N DDRJAANPRJIHGJ-UHFFFAOYSA-N 0.000 description 4
- 108010067755 dinitrophenyl-bovine serum albumin Proteins 0.000 description 4
- 239000003814 drug Substances 0.000 description 4
- 230000007613 environmental effect Effects 0.000 description 4
- 108010052295 fibrin fragment D Proteins 0.000 description 4
- 239000003365 glass fiber Substances 0.000 description 4
- 238000007726 management method Methods 0.000 description 4
- 238000012544 monitoring process Methods 0.000 description 4
- 230000005405 multipole Effects 0.000 description 4
- 238000001208 nuclear magnetic resonance pulse sequence Methods 0.000 description 4
- 238000007781 pre-processing Methods 0.000 description 4
- 102000004196 processed proteins & peptides Human genes 0.000 description 4
- 230000001681 protective effect Effects 0.000 description 4
- 230000005855 radiation Effects 0.000 description 4
- 238000013515 script Methods 0.000 description 4
- 210000002966 serum Anatomy 0.000 description 4
- 230000001360 synchronised effect Effects 0.000 description 4
- 210000002700 urine Anatomy 0.000 description 4
- 108010088751 Albumins Proteins 0.000 description 3
- 102000009027 Albumins Human genes 0.000 description 3
- 241000283707 Capra Species 0.000 description 3
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 3
- 102000004190 Enzymes Human genes 0.000 description 3
- 108090000790 Enzymes Proteins 0.000 description 3
- 102000011026 Fatty Acid Binding Protein 3 Human genes 0.000 description 3
- 108010062715 Fatty Acid Binding Protein 3 Proteins 0.000 description 3
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 3
- 230000008901 benefit Effects 0.000 description 3
- 239000012472 biological sample Substances 0.000 description 3
- 239000002041 carbon nanotube Substances 0.000 description 3
- 229910021393 carbon nanotube Inorganic materials 0.000 description 3
- 229920002678 cellulose Polymers 0.000 description 3
- 239000001913 cellulose Substances 0.000 description 3
- 238000006243 chemical reaction Methods 0.000 description 3
- 235000012000 cholesterol Nutrition 0.000 description 3
- 238000002405 diagnostic procedure Methods 0.000 description 3
- 238000005516 engineering process Methods 0.000 description 3
- 238000002474 experimental method Methods 0.000 description 3
- 239000007789 gas Substances 0.000 description 3
- 229940088597 hormone Drugs 0.000 description 3
- 239000005556 hormone Substances 0.000 description 3
- 238000002329 infrared spectrum Methods 0.000 description 3
- 238000011068 loading method Methods 0.000 description 3
- 230000014759 maintenance of location Effects 0.000 description 3
- 238000013507 mapping Methods 0.000 description 3
- 229910052751 metal Inorganic materials 0.000 description 3
- 239000002184 metal Substances 0.000 description 3
- 238000007837 multiplex assay Methods 0.000 description 3
- 230000007935 neutral effect Effects 0.000 description 3
- 210000002381 plasma Anatomy 0.000 description 3
- 229920000642 polymer Polymers 0.000 description 3
- 239000011148 porous material Substances 0.000 description 3
- 239000000047 product Substances 0.000 description 3
- 238000004445 quantitative analysis Methods 0.000 description 3
- 239000007790 solid phase Substances 0.000 description 3
- 238000005406 washing Methods 0.000 description 3
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 3
- UFBJCMHMOXMLKC-UHFFFAOYSA-N 2,4-dinitrophenol Chemical compound OC1=CC=C([N+]([O-])=O)C=C1[N+]([O-])=O UFBJCMHMOXMLKC-UHFFFAOYSA-N 0.000 description 2
- 108091023037 Aptamer Proteins 0.000 description 2
- BPYKTIZUTYGOLE-IFADSCNNSA-N Bilirubin Chemical compound N1C(=O)C(C)=C(C=C)\C1=C\C1=C(C)C(CCC(O)=O)=C(CC2=C(C(C)=C(\C=C/3C(=C(C=C)C(=O)N\3)C)N2)CCC(O)=O)N1 BPYKTIZUTYGOLE-IFADSCNNSA-N 0.000 description 2
- 101800000407 Brain natriuretic peptide 32 Proteins 0.000 description 2
- 102400000667 Brain natriuretic peptide 32 Human genes 0.000 description 2
- 101800002247 Brain natriuretic peptide 45 Proteins 0.000 description 2
- 108010074051 C-Reactive Protein Proteins 0.000 description 2
- 102100032752 C-reactive protein Human genes 0.000 description 2
- 108010047041 Complementarity Determining Regions Proteins 0.000 description 2
- 102000004420 Creatine Kinase Human genes 0.000 description 2
- 108010042126 Creatine kinase Proteins 0.000 description 2
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 2
- 206010028980 Neoplasm Diseases 0.000 description 2
- 239000004677 Nylon Substances 0.000 description 2
- CXOFVDLJLONNDW-UHFFFAOYSA-N Phenytoin Chemical compound N1C(=O)NC(=O)C1(C=1C=CC=CC=1)C1=CC=CC=C1 CXOFVDLJLONNDW-UHFFFAOYSA-N 0.000 description 2
- 102000004160 Phosphoric Monoester Hydrolases Human genes 0.000 description 2
- 108090000608 Phosphoric Monoester Hydrolases Proteins 0.000 description 2
- RJKFOVLPORLFTN-LEKSSAKUSA-N Progesterone Chemical compound C1CC2=CC(=O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H](C(=O)C)[C@@]1(C)CC2 RJKFOVLPORLFTN-LEKSSAKUSA-N 0.000 description 2
- 108010072866 Prostate-Specific Antigen Proteins 0.000 description 2
- 102100038358 Prostate-specific antigen Human genes 0.000 description 2
- LCTONWCANYUPML-UHFFFAOYSA-N Pyruvic acid Chemical compound CC(=O)C(O)=O LCTONWCANYUPML-UHFFFAOYSA-N 0.000 description 2
- 238000001069 Raman spectroscopy Methods 0.000 description 2
- MUMGGOZAMZWBJJ-DYKIIFRCSA-N Testostosterone Chemical compound O=C1CC[C@]2(C)[C@H]3CC[C@](C)([C@H](CC4)O)[C@@H]4[C@@H]3CCC2=C1 MUMGGOZAMZWBJJ-DYKIIFRCSA-N 0.000 description 2
- NIJJYAXOARWZEE-UHFFFAOYSA-N Valproic acid Chemical compound CCCC(C(O)=O)CCC NIJJYAXOARWZEE-UHFFFAOYSA-N 0.000 description 2
- 241000700605 Viruses Species 0.000 description 2
- 230000003213 activating effect Effects 0.000 description 2
- 230000003321 amplification Effects 0.000 description 2
- 210000001742 aqueous humor Anatomy 0.000 description 2
- 230000015572 biosynthetic process Effects 0.000 description 2
- 210000001124 body fluid Anatomy 0.000 description 2
- 239000010839 body fluid Substances 0.000 description 2
- 201000011510 cancer Diseases 0.000 description 2
- 210000004027 cell Anatomy 0.000 description 2
- 239000003153 chemical reaction reagent Substances 0.000 description 2
- 239000003086 colorant Substances 0.000 description 2
- 230000000295 complement effect Effects 0.000 description 2
- 238000012937 correction Methods 0.000 description 2
- CVSVTCORWBXHQV-UHFFFAOYSA-N creatine Chemical compound NC(=[NH2+])N(C)CC([O-])=O CVSVTCORWBXHQV-UHFFFAOYSA-N 0.000 description 2
- 229940109239 creatinine Drugs 0.000 description 2
- 229920006037 cross link polymer Polymers 0.000 description 2
- 238000007405 data analysis Methods 0.000 description 2
- 239000003599 detergent Substances 0.000 description 2
- 238000003745 diagnosis Methods 0.000 description 2
- 238000009826 distribution Methods 0.000 description 2
- 229940079593 drug Drugs 0.000 description 2
- 230000009977 dual effect Effects 0.000 description 2
- 239000000975 dye Substances 0.000 description 2
- 238000000835 electrochemical detection Methods 0.000 description 2
- 238000001704 evaporation Methods 0.000 description 2
- 230000008020 evaporation Effects 0.000 description 2
- 239000007850 fluorescent dye Substances 0.000 description 2
- 235000013305 food Nutrition 0.000 description 2
- 239000008103 glucose Substances 0.000 description 2
- JYGXADMDTFJGBT-VWUMJDOOSA-N hydrocortisone Chemical compound O=C1CC[C@]2(C)[C@H]3[C@@H](O)C[C@](C)([C@@](CC4)(O)C(=O)CO)[C@@H]4[C@@H]3CCC2=C1 JYGXADMDTFJGBT-VWUMJDOOSA-N 0.000 description 2
- 230000006872 improvement Effects 0.000 description 2
- 238000007373 indentation Methods 0.000 description 2
- 238000009434 installation Methods 0.000 description 2
- 230000002452 interceptive effect Effects 0.000 description 2
- 238000002372 labelling Methods 0.000 description 2
- HPNRHPKXQZSDFX-OAQDCNSJSA-N nesiritide Chemical compound C([C@H]1C(=O)NCC(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@H](C(N[C@@H](CO)C(=O)N[C@@H](CO)C(=O)N[C@@H](CO)C(=O)N[C@@H](CO)C(=O)NCC(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)N[C@@H](CSSC[C@@H](C(=O)N1)NC(=O)CNC(=O)[C@H](CO)NC(=O)CNC(=O)[C@H](CCC(N)=O)NC(=O)[C@@H](NC(=O)[C@H](CCSC)NC(=O)[C@H](CCCCN)NC(=O)[C@H]1N(CCC1)C(=O)[C@@H](N)CO)C(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC=1N=CNC=1)C(O)=O)=O)[C@@H](C)CC)C1=CC=CC=C1 HPNRHPKXQZSDFX-OAQDCNSJSA-N 0.000 description 2
- 238000003199 nucleic acid amplification method Methods 0.000 description 2
- 239000002773 nucleotide Substances 0.000 description 2
- 125000003729 nucleotide group Chemical group 0.000 description 2
- 229920001778 nylon Polymers 0.000 description 2
- 238000013021 overheating Methods 0.000 description 2
- 239000002245 particle Substances 0.000 description 2
- 229960002036 phenytoin Drugs 0.000 description 2
- 239000004033 plastic Substances 0.000 description 2
- 229920003023 plastic Polymers 0.000 description 2
- 229920000728 polyester Polymers 0.000 description 2
- 238000002360 preparation method Methods 0.000 description 2
- 230000008569 process Effects 0.000 description 2
- 210000003296 saliva Anatomy 0.000 description 2
- 238000007493 shaping process Methods 0.000 description 2
- 238000007619 statistical method Methods 0.000 description 2
- 208000024891 symptom Diseases 0.000 description 2
- ZFXYFBGIUFBOJW-UHFFFAOYSA-N theophylline Chemical compound O=C1N(C)C(=O)N(C)C2=C1NC=N2 ZFXYFBGIUFBOJW-UHFFFAOYSA-N 0.000 description 2
- 238000012384 transportation and delivery Methods 0.000 description 2
- 238000000108 ultra-filtration Methods 0.000 description 2
- 230000000007 visual effect Effects 0.000 description 2
- PJVWKTKQMONHTI-UHFFFAOYSA-N warfarin Chemical compound OC=1C2=CC=CC=C2OC(=O)C=1C(CC(=O)C)C1=CC=CC=C1 PJVWKTKQMONHTI-UHFFFAOYSA-N 0.000 description 2
- HDTRYLNUVZCQOY-UHFFFAOYSA-N α-D-glucopyranosyl-α-D-glucopyranoside Natural products OC1C(O)C(O)C(CO)OC1OC1C(O)C(O)C(O)C(CO)O1 HDTRYLNUVZCQOY-UHFFFAOYSA-N 0.000 description 1
- PROQIPRRNZUXQM-UHFFFAOYSA-N (16alpha,17betaOH)-Estra-1,3,5(10)-triene-3,16,17-triol Natural products OC1=CC=C2C3CCC(C)(C(C(O)C4)O)C4C3CCC2=C1 PROQIPRRNZUXQM-UHFFFAOYSA-N 0.000 description 1
- VOXZDWNPVJITMN-ZBRFXRBCSA-N 17β-estradiol Chemical compound OC1=CC=C2[C@H]3CC[C@](C)([C@H](CC4)O)[C@@H]4[C@@H]3CCC2=C1 VOXZDWNPVJITMN-ZBRFXRBCSA-N 0.000 description 1
- 229920000936 Agarose Polymers 0.000 description 1
- 229910000838 Al alloy Inorganic materials 0.000 description 1
- 102100036475 Alanine aminotransferase 1 Human genes 0.000 description 1
- 108010082126 Alanine transaminase Proteins 0.000 description 1
- 239000012099 Alexa Fluor family Substances 0.000 description 1
- 239000004382 Amylase Substances 0.000 description 1
- 108010065511 Amylases Proteins 0.000 description 1
- 102000013142 Amylases Human genes 0.000 description 1
- 108010003415 Aspartate Aminotransferases Proteins 0.000 description 1
- 102000004625 Aspartate Aminotransferases Human genes 0.000 description 1
- 241000282672 Ateles sp. Species 0.000 description 1
- 208000023275 Autoimmune disease Diseases 0.000 description 1
- 241000894006 Bacteria Species 0.000 description 1
- 102000055006 Calcitonin Human genes 0.000 description 1
- 108060001064 Calcitonin Proteins 0.000 description 1
- 208000024172 Cardiovascular disease Diseases 0.000 description 1
- 102000011632 Caseins Human genes 0.000 description 1
- 108010076119 Caseins Proteins 0.000 description 1
- 102000011022 Chorionic Gonadotropin Human genes 0.000 description 1
- 108010062540 Chorionic Gonadotropin Proteins 0.000 description 1
- 208000035473 Communicable disease Diseases 0.000 description 1
- XUIIKFGFIJCVMT-GFCCVEGCSA-N D-thyroxine Chemical compound IC1=CC(C[C@@H](N)C(O)=O)=CC(I)=C1OC1=CC(I)=C(O)C(I)=C1 XUIIKFGFIJCVMT-GFCCVEGCSA-N 0.000 description 1
- 229910000722 Didymium Inorganic materials 0.000 description 1
- LTMHDMANZUZIPE-AMTYYWEZSA-N Digoxin Natural products O([C@H]1[C@H](C)O[C@H](O[C@@H]2C[C@@H]3[C@@](C)([C@@H]4[C@H]([C@]5(O)[C@](C)([C@H](O)C4)[C@H](C4=CC(=O)OC4)CC5)CC3)CC2)C[C@@H]1O)[C@H]1O[C@H](C)[C@@H](O[C@H]2O[C@@H](C)[C@H](O)[C@@H](O)C2)[C@@H](O)C1 LTMHDMANZUZIPE-AMTYYWEZSA-N 0.000 description 1
- 206010013654 Drug abuse Diseases 0.000 description 1
- KCXVZYZYPLLWCC-UHFFFAOYSA-N EDTA Chemical compound OC(=O)CN(CC(O)=O)CCN(CC(O)=O)CC(O)=O KCXVZYZYPLLWCC-UHFFFAOYSA-N 0.000 description 1
- 241000283074 Equus asinus Species 0.000 description 1
- 108010003471 Fetal Proteins Proteins 0.000 description 1
- 102000004641 Fetal Proteins Human genes 0.000 description 1
- 102000012673 Follicle Stimulating Hormone Human genes 0.000 description 1
- 108010079345 Follicle Stimulating Hormone Proteins 0.000 description 1
- GYHNNYVSQQEPJS-UHFFFAOYSA-N Gallium Chemical compound [Ga] GYHNNYVSQQEPJS-UHFFFAOYSA-N 0.000 description 1
- 101100226596 Gallus gallus FABP gene Proteins 0.000 description 1
- CEAZRRDELHUEMR-URQXQFDESA-N Gentamicin Chemical compound O1[C@H](C(C)NC)CC[C@@H](N)[C@H]1O[C@H]1[C@H](O)[C@@H](O[C@@H]2[C@@H]([C@@H](NC)[C@@](C)(O)CO2)O)[C@H](N)C[C@@H]1N CEAZRRDELHUEMR-URQXQFDESA-N 0.000 description 1
- 229930182566 Gentamicin Natural products 0.000 description 1
- 108010044091 Globulins Proteins 0.000 description 1
- 102000006395 Globulins Human genes 0.000 description 1
- 102400000321 Glucagon Human genes 0.000 description 1
- 108060003199 Glucagon Proteins 0.000 description 1
- 102000003886 Glycoproteins Human genes 0.000 description 1
- 108090000288 Glycoproteins Proteins 0.000 description 1
- 108010051696 Growth Hormone Proteins 0.000 description 1
- 102000014702 Haptoglobin Human genes 0.000 description 1
- 108050005077 Haptoglobin Proteins 0.000 description 1
- 102000001554 Hemoglobins Human genes 0.000 description 1
- 108010054147 Hemoglobins Proteins 0.000 description 1
- 102000003864 Human Follicle Stimulating Hormone Human genes 0.000 description 1
- 108010082302 Human Follicle Stimulating Hormone Proteins 0.000 description 1
- 108010003272 Hyaluronate lyase Proteins 0.000 description 1
- 206010020751 Hypersensitivity Diseases 0.000 description 1
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 1
- 108010044467 Isoenzymes Proteins 0.000 description 1
- FFFHZYDWPBMWHY-VKHMYHEASA-N L-homocysteine Chemical compound OC(=O)[C@@H](N)CCS FFFHZYDWPBMWHY-VKHMYHEASA-N 0.000 description 1
- 102000003855 L-lactate dehydrogenase Human genes 0.000 description 1
- 108700023483 L-lactate dehydrogenases Proteins 0.000 description 1
- 238000012897 Levenberg–Marquardt algorithm Methods 0.000 description 1
- WHXSMMKQMYFTQS-UHFFFAOYSA-N Lithium Chemical compound [Li] WHXSMMKQMYFTQS-UHFFFAOYSA-N 0.000 description 1
- 102000009151 Luteinizing Hormone Human genes 0.000 description 1
- 108010073521 Luteinizing Hormone Proteins 0.000 description 1
- 108010052285 Membrane Proteins Proteins 0.000 description 1
- 102000018697 Membrane Proteins Human genes 0.000 description 1
- 229920001410 Microfiber Polymers 0.000 description 1
- 102100030856 Myoglobin Human genes 0.000 description 1
- 108010062374 Myoglobin Proteins 0.000 description 1
- PHVGLTMQBUFIQQ-UHFFFAOYSA-N Nortryptiline Chemical compound C1CC2=CC=CC=C2C(=CCCNC)C2=CC=CC=C21 PHVGLTMQBUFIQQ-UHFFFAOYSA-N 0.000 description 1
- 102000003982 Parathyroid hormone Human genes 0.000 description 1
- 108090000445 Parathyroid hormone Proteins 0.000 description 1
- 239000004952 Polyamide Substances 0.000 description 1
- 239000004695 Polyether sulfone Substances 0.000 description 1
- 239000004698 Polyethylene Substances 0.000 description 1
- 229920001213 Polysorbate 20 Polymers 0.000 description 1
- ZLMJMSJWJFRBEC-UHFFFAOYSA-N Potassium Chemical compound [K] ZLMJMSJWJFRBEC-UHFFFAOYSA-N 0.000 description 1
- 206010036790 Productive cough Diseases 0.000 description 1
- 102100038803 Somatotropin Human genes 0.000 description 1
- 238000000692 Student's t-test Methods 0.000 description 1
- 206010043458 Thirst Diseases 0.000 description 1
- AUYYCJSJGJYCDS-LBPRGKRZSA-N Thyrolar Chemical compound IC1=CC(C[C@H](N)C(O)=O)=CC(I)=C1OC1=CC=C(O)C(I)=C1 AUYYCJSJGJYCDS-LBPRGKRZSA-N 0.000 description 1
- 102000004338 Transferrin Human genes 0.000 description 1
- 108090000901 Transferrin Proteins 0.000 description 1
- HDTRYLNUVZCQOY-WSWWMNSNSA-N Trehalose Natural products O[C@@H]1[C@@H](O)[C@@H](O)[C@@H](CO)O[C@@H]1O[C@@H]1[C@H](O)[C@@H](O)[C@@H](O)[C@@H](CO)O1 HDTRYLNUVZCQOY-WSWWMNSNSA-N 0.000 description 1
- 239000007983 Tris buffer Substances 0.000 description 1
- 102100036859 Troponin I, cardiac muscle Human genes 0.000 description 1
- 101710128251 Troponin I, cardiac muscle Proteins 0.000 description 1
- LEHOTFFKMJEONL-UHFFFAOYSA-N Uric Acid Chemical compound N1C(=O)NC(=O)C2=C1NC(=O)N2 LEHOTFFKMJEONL-UHFFFAOYSA-N 0.000 description 1
- TVWHNULVHGKJHS-UHFFFAOYSA-N Uric acid Natural products N1C(=O)NC(=O)C2NC(=O)NC21 TVWHNULVHGKJHS-UHFFFAOYSA-N 0.000 description 1
- 108010059993 Vancomycin Proteins 0.000 description 1
- PNNCWTXUWKENPE-UHFFFAOYSA-N [N].NC(N)=O Chemical compound [N].NC(N)=O PNNCWTXUWKENPE-UHFFFAOYSA-N 0.000 description 1
- 238000010521 absorption reaction Methods 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- NIXOWILDQLNWCW-UHFFFAOYSA-N acrylic acid group Chemical group C(C=C)(=O)O NIXOWILDQLNWCW-UHFFFAOYSA-N 0.000 description 1
- 229920006243 acrylic copolymer Polymers 0.000 description 1
- 239000003513 alkali Substances 0.000 description 1
- 230000007815 allergy Effects 0.000 description 1
- HDTRYLNUVZCQOY-LIZSDCNHSA-N alpha,alpha-trehalose Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@@H]1O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 HDTRYLNUVZCQOY-LIZSDCNHSA-N 0.000 description 1
- 229960000836 amitriptyline Drugs 0.000 description 1
- KRMDCWKBEZIMAB-UHFFFAOYSA-N amitriptyline Chemical compound C1CC2=CC=CC=C2C(=CCCN(C)C)C2=CC=CC=C21 KRMDCWKBEZIMAB-UHFFFAOYSA-N 0.000 description 1
- 210000004381 amniotic fluid Anatomy 0.000 description 1
- 235000019418 amylase Nutrition 0.000 description 1
- 238000000540 analysis of variance Methods 0.000 description 1
- 239000006117 anti-reflective coating Substances 0.000 description 1
- 230000003208 anti-thyroid effect Effects 0.000 description 1
- 239000002246 antineoplastic agent Substances 0.000 description 1
- 229940043671 antithyroid preparations Drugs 0.000 description 1
- 238000013459 approach Methods 0.000 description 1
- 230000000712 assembly Effects 0.000 description 1
- 238000000429 assembly Methods 0.000 description 1
- 230000000386 athletic effect Effects 0.000 description 1
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 1
- WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 description 1
- 230000002146 bilateral effect Effects 0.000 description 1
- 230000006287 biotinylation Effects 0.000 description 1
- 238000007413 biotinylation Methods 0.000 description 1
- 229910052797 bismuth Inorganic materials 0.000 description 1
- JCXGWMGPZLAOME-UHFFFAOYSA-N bismuth atom Chemical compound [Bi] JCXGWMGPZLAOME-UHFFFAOYSA-N 0.000 description 1
- 210000000601 blood cell Anatomy 0.000 description 1
- 239000006227 byproduct Substances 0.000 description 1
- 229960004015 calcitonin Drugs 0.000 description 1
- BBBFJLBPOGFECG-VJVYQDLKSA-N calcitonin Chemical compound N([C@H](C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC=1NC=NC=1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC=1C=CC(O)=CC=1)C(=O)N1[C@@H](CCC1)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H]([C@@H](C)O)C(=O)NCC(=O)N[C@@H](CO)C(=O)NCC(=O)N[C@@H]([C@@H](C)O)C(=O)N1[C@@H](CCC1)C(N)=O)C(C)C)C(=O)[C@@H]1CSSC[C@H](N)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CO)C(=O)N[C@@H]([C@@H](C)O)C(=O)N1 BBBFJLBPOGFECG-VJVYQDLKSA-N 0.000 description 1
- 238000004422 calculation algorithm Methods 0.000 description 1
- 238000004364 calculation method Methods 0.000 description 1
- 238000011088 calibration curve Methods 0.000 description 1
- FFGPTBGBLSHEPO-UHFFFAOYSA-N carbamazepine Chemical compound C1=CC2=CC=CC=C2N(C(=O)N)C2=CC=CC=C21 FFGPTBGBLSHEPO-UHFFFAOYSA-N 0.000 description 1
- 229960000623 carbamazepine Drugs 0.000 description 1
- 239000005018 casein Substances 0.000 description 1
- BECPQYXYKAMYBN-UHFFFAOYSA-N casein, tech. Chemical compound NCCCCC(C(O)=O)N=C(O)C(CC(O)=O)N=C(O)C(CCC(O)=N)N=C(O)C(CC(C)C)N=C(O)C(CCC(O)=O)N=C(O)C(CC(O)=O)N=C(O)C(CCC(O)=O)N=C(O)C(C(C)O)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=O)N=C(O)C(CCC(O)=O)N=C(O)C(COP(O)(O)=O)N=C(O)C(CCC(O)=N)N=C(O)C(N)CC1=CC=CC=C1 BECPQYXYKAMYBN-UHFFFAOYSA-N 0.000 description 1
- 235000021240 caseins Nutrition 0.000 description 1
- 210000002421 cell wall Anatomy 0.000 description 1
- 230000001413 cellular effect Effects 0.000 description 1
- 229920002301 cellulose acetate Polymers 0.000 description 1
- 210000003756 cervix mucus Anatomy 0.000 description 1
- 229940015047 chorionic gonadotropin Drugs 0.000 description 1
- 230000008045 co-localization Effects 0.000 description 1
- 239000000084 colloidal system Substances 0.000 description 1
- 238000004590 computer program Methods 0.000 description 1
- 239000000356 contaminant Substances 0.000 description 1
- 238000011109 contamination Methods 0.000 description 1
- 229940072645 coumadin Drugs 0.000 description 1
- 230000008878 coupling Effects 0.000 description 1
- 238000010168 coupling process Methods 0.000 description 1
- 238000005859 coupling reaction Methods 0.000 description 1
- 229960003624 creatine Drugs 0.000 description 1
- 239000006046 creatine Substances 0.000 description 1
- 238000013481 data capture Methods 0.000 description 1
- 238000013480 data collection Methods 0.000 description 1
- 238000013523 data management Methods 0.000 description 1
- 238000013500 data storage Methods 0.000 description 1
- 230000008021 deposition Effects 0.000 description 1
- 238000009792 diffusion process Methods 0.000 description 1
- LTMHDMANZUZIPE-PUGKRICDSA-N digoxin Chemical compound C1[C@H](O)[C@H](O)[C@@H](C)O[C@H]1O[C@@H]1[C@@H](C)O[C@@H](O[C@@H]2[C@H](O[C@@H](O[C@@H]3C[C@@H]4[C@]([C@@H]5[C@H]([C@]6(CC[C@@H]([C@@]6(C)[C@H](O)C5)C=5COC(=O)C=5)O)CC4)(C)CC3)C[C@@H]2O)C)C[C@@H]1O LTMHDMANZUZIPE-PUGKRICDSA-N 0.000 description 1
- 229960005156 digoxin Drugs 0.000 description 1
- LTMHDMANZUZIPE-UHFFFAOYSA-N digoxine Natural products C1C(O)C(O)C(C)OC1OC1C(C)OC(OC2C(OC(OC3CC4C(C5C(C6(CCC(C6(C)C(O)C5)C=5COC(=O)C=5)O)CC4)(C)CC3)CC2O)C)CC1O LTMHDMANZUZIPE-UHFFFAOYSA-N 0.000 description 1
- 238000007865 diluting Methods 0.000 description 1
- 239000000539 dimer Substances 0.000 description 1
- 238000003618 dip coating Methods 0.000 description 1
- 238000002845 discoloration Methods 0.000 description 1
- 239000006185 dispersion Substances 0.000 description 1
- 239000000428 dust Substances 0.000 description 1
- 230000005684 electric field Effects 0.000 description 1
- 230000005611 electricity Effects 0.000 description 1
- 210000000750 endocrine system Anatomy 0.000 description 1
- 229960005309 estradiol Drugs 0.000 description 1
- 229930182833 estradiol Natural products 0.000 description 1
- PROQIPRRNZUXQM-ZXXIGWHRSA-N estriol Chemical compound OC1=CC=C2[C@H]3CC[C@](C)([C@H]([C@H](O)C4)O)[C@@H]4[C@@H]3CCC2=C1 PROQIPRRNZUXQM-ZXXIGWHRSA-N 0.000 description 1
- 229960001348 estriol Drugs 0.000 description 1
- 229940011871 estrogen Drugs 0.000 description 1
- 239000000262 estrogen Substances 0.000 description 1
- 238000011156 evaluation Methods 0.000 description 1
- 230000007717 exclusion Effects 0.000 description 1
- 230000001747 exhibiting effect Effects 0.000 description 1
- 239000003172 expectorant agent Substances 0.000 description 1
- 239000000284 extract Substances 0.000 description 1
- 210000000887 face Anatomy 0.000 description 1
- 238000011049 filling Methods 0.000 description 1
- 238000001914 filtration Methods 0.000 description 1
- 239000012847 fine chemical Substances 0.000 description 1
- 238000001917 fluorescence detection Methods 0.000 description 1
- 238000011010 flushing procedure Methods 0.000 description 1
- 229940028334 follicle stimulating hormone Drugs 0.000 description 1
- 229910052733 gallium Inorganic materials 0.000 description 1
- 229960002518 gentamicin Drugs 0.000 description 1
- MASNOZXLGMXCHN-ZLPAWPGGSA-N glucagon Chemical compound C([C@@H](C(=O)N[C@H](C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC=1C2=CC=CC=C2NC=1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H]([C@@H](C)O)C(O)=O)C(C)C)NC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](C)NC(=O)[C@H](CCCNC(N)=N)NC(=O)[C@H](CCCNC(N)=N)NC(=O)[C@H](CO)NC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC=1C=CC(O)=CC=1)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CO)NC(=O)[C@H](CC=1C=CC(O)=CC=1)NC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CO)NC(=O)[C@@H](NC(=O)[C@H](CC=1C=CC=CC=1)NC(=O)[C@@H](NC(=O)CNC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CO)NC(=O)[C@@H](N)CC=1NC=NC=1)[C@@H](C)O)[C@@H](C)O)C1=CC=CC=C1 MASNOZXLGMXCHN-ZLPAWPGGSA-N 0.000 description 1
- 229960004666 glucagon Drugs 0.000 description 1
- 229960001031 glucose Drugs 0.000 description 1
- 150000004676 glycans Chemical class 0.000 description 1
- 238000009499 grossing Methods 0.000 description 1
- 150000003278 haem Chemical class 0.000 description 1
- 208000019622 heart disease Diseases 0.000 description 1
- 208000002672 hepatitis B Diseases 0.000 description 1
- 238000004128 high performance liquid chromatography Methods 0.000 description 1
- 229960000890 hydrocortisone Drugs 0.000 description 1
- 230000005660 hydrophilic surface Effects 0.000 description 1
- 230000002209 hydrophobic effect Effects 0.000 description 1
- 230000005661 hydrophobic surface Effects 0.000 description 1
- 238000005286 illumination Methods 0.000 description 1
- 210000000987 immune system Anatomy 0.000 description 1
- 238000003018 immunoassay Methods 0.000 description 1
- 239000012535 impurity Substances 0.000 description 1
- 238000000338 in vitro Methods 0.000 description 1
- 229910052738 indium Inorganic materials 0.000 description 1
- APFVFJFRJDLVQX-UHFFFAOYSA-N indium atom Chemical compound [In] APFVFJFRJDLVQX-UHFFFAOYSA-N 0.000 description 1
- 208000015181 infectious disease Diseases 0.000 description 1
- 238000001746 injection moulding Methods 0.000 description 1
- 230000010354 integration Effects 0.000 description 1
- 230000003993 interaction Effects 0.000 description 1
- 239000003014 ion exchange membrane Substances 0.000 description 1
- 229960000318 kanamycin Drugs 0.000 description 1
- 229930027917 kanamycin Natural products 0.000 description 1
- SBUJHOSQTJFQJX-NOAMYHISSA-N kanamycin Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CN)O[C@@H]1O[C@H]1[C@H](O)[C@@H](O[C@@H]2[C@@H]([C@@H](N)[C@H](O)[C@@H](CO)O2)O)[C@H](N)C[C@@H]1N SBUJHOSQTJFQJX-NOAMYHISSA-N 0.000 description 1
- 229930182823 kanamycin A Natural products 0.000 description 1
- 230000000670 limiting effect Effects 0.000 description 1
- 239000002502 liposome Substances 0.000 description 1
- 239000007788 liquid Substances 0.000 description 1
- 229910052744 lithium Inorganic materials 0.000 description 1
- 229940040129 luteinizing hormone Drugs 0.000 description 1
- 239000012139 lysis buffer Substances 0.000 description 1
- 229920002521 macromolecule Polymers 0.000 description 1
- 230000007257 malfunction Effects 0.000 description 1
- 239000011159 matrix material Substances 0.000 description 1
- 229910001092 metal group alloy Inorganic materials 0.000 description 1
- 150000002739 metals Chemical class 0.000 description 1
- 238000002493 microarray Methods 0.000 description 1
- 239000003658 microfiber Substances 0.000 description 1
- 230000003228 microsomal effect Effects 0.000 description 1
- 239000003068 molecular probe Substances 0.000 description 1
- 229940066491 mucolytics Drugs 0.000 description 1
- 210000003097 mucus Anatomy 0.000 description 1
- 239000002071 nanotube Substances 0.000 description 1
- 230000009871 nonspecific binding Effects 0.000 description 1
- 229960001158 nortriptyline Drugs 0.000 description 1
- 235000015097 nutrients Nutrition 0.000 description 1
- 239000003960 organic solvent Substances 0.000 description 1
- 230000008520 organization Effects 0.000 description 1
- 229940043515 other immunoglobulins in atc Drugs 0.000 description 1
- 239000001301 oxygen Substances 0.000 description 1
- 229910052760 oxygen Inorganic materials 0.000 description 1
- 238000012856 packing Methods 0.000 description 1
- FIKAKWIAUPDISJ-UHFFFAOYSA-L paraquat dichloride Chemical compound [Cl-].[Cl-].C1=C[N+](C)=CC=C1C1=CC=[N+](C)C=C1 FIKAKWIAUPDISJ-UHFFFAOYSA-L 0.000 description 1
- 239000000199 parathyroid hormone Substances 0.000 description 1
- 229960001319 parathyroid hormone Drugs 0.000 description 1
- 230000036961 partial effect Effects 0.000 description 1
- 239000013618 particulate matter Substances 0.000 description 1
- 230000007170 pathology Effects 0.000 description 1
- 230000000737 periodic effect Effects 0.000 description 1
- DDBREPKUVSBGFI-UHFFFAOYSA-N phenobarbital Chemical compound C=1C=CC=CC=1C1(CC)C(=O)NC(=O)NC1=O DDBREPKUVSBGFI-UHFFFAOYSA-N 0.000 description 1
- 229960002695 phenobarbital Drugs 0.000 description 1
- 229920002401 polyacrylamide Polymers 0.000 description 1
- 229920002647 polyamide Polymers 0.000 description 1
- 229920000867 polyelectrolyte Polymers 0.000 description 1
- 229920006393 polyether sulfone Polymers 0.000 description 1
- 229920000573 polyethylene Polymers 0.000 description 1
- 229920006254 polymer film Polymers 0.000 description 1
- 239000002861 polymer material Substances 0.000 description 1
- 239000000256 polyoxyethylene sorbitan monolaurate Substances 0.000 description 1
- 235000010486 polyoxyethylene sorbitan monolaurate Nutrition 0.000 description 1
- 229920001282 polysaccharide Polymers 0.000 description 1
- 239000005017 polysaccharide Substances 0.000 description 1
- 239000004800 polyvinyl chloride Substances 0.000 description 1
- 229910052700 potassium Inorganic materials 0.000 description 1
- 239000011591 potassium Substances 0.000 description 1
- 239000003755 preservative agent Substances 0.000 description 1
- 239000000186 progesterone Substances 0.000 description 1
- 229960003387 progesterone Drugs 0.000 description 1
- 238000003498 protein array Methods 0.000 description 1
- 229940107700 pyruvic acid Drugs 0.000 description 1
- 238000004451 qualitative analysis Methods 0.000 description 1
- 238000011002 quantification Methods 0.000 description 1
- 230000002285 radioactive effect Effects 0.000 description 1
- 229910052761 rare earth metal Inorganic materials 0.000 description 1
- 230000003134 recirculating effect Effects 0.000 description 1
- 230000009467 reduction Effects 0.000 description 1
- 238000002310 reflectometry Methods 0.000 description 1
- 238000009877 rendering Methods 0.000 description 1
- 238000007789 sealing Methods 0.000 description 1
- 230000028327 secretion Effects 0.000 description 1
- 238000013207 serial dilution Methods 0.000 description 1
- 150000003384 small molecules Chemical class 0.000 description 1
- 229910052708 sodium Inorganic materials 0.000 description 1
- 239000011734 sodium Substances 0.000 description 1
- 238000005476 soldering Methods 0.000 description 1
- 239000007787 solid Substances 0.000 description 1
- 239000002904 solvent Substances 0.000 description 1
- 230000009870 specific binding Effects 0.000 description 1
- 238000011895 specific detection Methods 0.000 description 1
- 238000004611 spectroscopical analysis Methods 0.000 description 1
- 210000003802 sputum Anatomy 0.000 description 1
- 208000024794 sputum Diseases 0.000 description 1
- 239000010935 stainless steel Substances 0.000 description 1
- 229910001220 stainless steel Inorganic materials 0.000 description 1
- 239000010421 standard material Substances 0.000 description 1
- 230000003068 static effect Effects 0.000 description 1
- 230000004936 stimulating effect Effects 0.000 description 1
- 208000011117 substance-related disease Diseases 0.000 description 1
- 238000004416 surface enhanced Raman spectroscopy Methods 0.000 description 1
- 239000013076 target substance Substances 0.000 description 1
- 229910052714 tellurium Inorganic materials 0.000 description 1
- 229960003604 testosterone Drugs 0.000 description 1
- 229960000278 theophylline Drugs 0.000 description 1
- ANRHNWWPFJCPAZ-UHFFFAOYSA-M thionine Chemical compound [Cl-].C1=CC(N)=CC2=[S+]C3=CC(N)=CC=C3N=C21 ANRHNWWPFJCPAZ-UHFFFAOYSA-M 0.000 description 1
- 210000001685 thyroid gland Anatomy 0.000 description 1
- 229940034208 thyroxine Drugs 0.000 description 1
- XUIIKFGFIJCVMT-UHFFFAOYSA-N thyroxine-binding globulin Natural products IC1=CC(CC([NH3+])C([O-])=O)=CC(I)=C1OC1=CC(I)=C(O)C(I)=C1 XUIIKFGFIJCVMT-UHFFFAOYSA-N 0.000 description 1
- 210000001519 tissue Anatomy 0.000 description 1
- 239000003053 toxin Substances 0.000 description 1
- 231100000765 toxin Toxicity 0.000 description 1
- 108700012359 toxins Proteins 0.000 description 1
- 239000012581 transferrin Substances 0.000 description 1
- 230000032258 transport Effects 0.000 description 1
- 238000011269 treatment regimen Methods 0.000 description 1
- UFTFJSFQGQCHQW-UHFFFAOYSA-N triformin Chemical compound O=COCC(OC=O)COC=O UFTFJSFQGQCHQW-UHFFFAOYSA-N 0.000 description 1
- LENZDBCJOHFCAS-UHFFFAOYSA-N tris Chemical compound OCC(N)(CO)CO LENZDBCJOHFCAS-UHFFFAOYSA-N 0.000 description 1
- 229940116269 uric acid Drugs 0.000 description 1
- 238000002562 urinalysis Methods 0.000 description 1
- 238000001291 vacuum drying Methods 0.000 description 1
- 238000009777 vacuum freeze-drying Methods 0.000 description 1
- 229960000604 valproic acid Drugs 0.000 description 1
- 229960003165 vancomycin Drugs 0.000 description 1
- MYPYJXKWCTUITO-UHFFFAOYSA-N vancomycin Natural products O1C(C(=C2)Cl)=CC=C2C(O)C(C(NC(C2=CC(O)=CC(O)=C2C=2C(O)=CC=C3C=2)C(O)=O)=O)NC(=O)C3NC(=O)C2NC(=O)C(CC(N)=O)NC(=O)C(NC(=O)C(CC(C)C)NC)C(O)C(C=C3Cl)=CC=C3OC3=CC2=CC1=C3OC1OC(CO)C(O)C(O)C1OC1CC(C)(N)C(O)C(C)O1 MYPYJXKWCTUITO-UHFFFAOYSA-N 0.000 description 1
- MYPYJXKWCTUITO-LYRMYLQWSA-N vancomycin Chemical compound O([C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1OC1=C2C=C3C=C1OC1=CC=C(C=C1Cl)[C@@H](O)[C@H](C(N[C@@H](CC(N)=O)C(=O)N[C@H]3C(=O)N[C@H]1C(=O)N[C@H](C(N[C@@H](C3=CC(O)=CC(O)=C3C=3C(O)=CC=C1C=3)C(O)=O)=O)[C@H](O)C1=CC=C(C(=C1)Cl)O2)=O)NC(=O)[C@@H](CC(C)C)NC)[C@H]1C[C@](C)(N)[C@H](O)[C@H](C)O1 MYPYJXKWCTUITO-LYRMYLQWSA-N 0.000 description 1
- 125000000391 vinyl group Chemical group [H]C([*])=C([H])[H] 0.000 description 1
- 229920002554 vinyl polymer Polymers 0.000 description 1
- 229940088594 vitamin Drugs 0.000 description 1
- 229930003231 vitamin Natural products 0.000 description 1
- 235000013343 vitamin Nutrition 0.000 description 1
- 239000011782 vitamin Substances 0.000 description 1
- 229960005080 warfarin Drugs 0.000 description 1
- 238000003466 welding Methods 0.000 description 1
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/52—Use of compounds or compositions for colorimetric, spectrophotometric or fluorometric investigation, e.g. use of reagent paper and including single- and multilayer analytical elements
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N21/00—Investigating or analysing materials by the use of optical means, i.e. using sub-millimetre waves, infrared, visible or ultraviolet light
- G01N21/62—Systems in which the material investigated is excited whereby it emits light or causes a change in wavelength of the incident light
- G01N21/63—Systems in which the material investigated is excited whereby it emits light or causes a change in wavelength of the incident light optically excited
- G01N21/64—Fluorescence; Phosphorescence
- G01N21/6428—Measuring fluorescence of fluorescent products of reactions or of fluorochrome labelled reactive substances, e.g. measuring quenching effects, using measuring "optrodes"
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N21/00—Investigating or analysing materials by the use of optical means, i.e. using sub-millimetre waves, infrared, visible or ultraviolet light
- G01N21/75—Systems in which material is subjected to a chemical reaction, the progress or the result of the reaction being investigated
- G01N21/77—Systems in which material is subjected to a chemical reaction, the progress or the result of the reaction being investigated by observing the effect on a chemical indicator
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N21/00—Investigating or analysing materials by the use of optical means, i.e. using sub-millimetre waves, infrared, visible or ultraviolet light
- G01N21/84—Systems specially adapted for particular applications
- G01N21/8483—Investigating reagent band
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/531—Production of immunochemical test materials
- G01N33/532—Production of labelled immunochemicals
- G01N33/533—Production of labelled immunochemicals with fluorescent label
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/543—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals
- G01N33/54366—Apparatus specially adapted for solid-phase testing
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/543—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals
- G01N33/54366—Apparatus specially adapted for solid-phase testing
- G01N33/54386—Analytical elements
- G01N33/54387—Immunochromatographic test strips
- G01N33/54388—Immunochromatographic test strips based on lateral flow
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/58—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving labelled substances
- G01N33/582—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving labelled substances with fluorescent label
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N35/00—Automatic analysis not limited to methods or materials provided for in any single one of groups G01N1/00 - G01N33/00; Handling materials therefor
- G01N35/00029—Automatic analysis not limited to methods or materials provided for in any single one of groups G01N1/00 - G01N33/00; Handling materials therefor provided with flat sample substrates, e.g. slides
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N21/00—Investigating or analysing materials by the use of optical means, i.e. using sub-millimetre waves, infrared, visible or ultraviolet light
- G01N21/62—Systems in which the material investigated is excited whereby it emits light or causes a change in wavelength of the incident light
- G01N21/63—Systems in which the material investigated is excited whereby it emits light or causes a change in wavelength of the incident light optically excited
- G01N21/64—Fluorescence; Phosphorescence
- G01N2021/6417—Spectrofluorimetric devices
- G01N2021/6419—Excitation at two or more wavelengths
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N21/00—Investigating or analysing materials by the use of optical means, i.e. using sub-millimetre waves, infrared, visible or ultraviolet light
- G01N21/62—Systems in which the material investigated is excited whereby it emits light or causes a change in wavelength of the incident light
- G01N21/63—Systems in which the material investigated is excited whereby it emits light or causes a change in wavelength of the incident light optically excited
- G01N21/64—Fluorescence; Phosphorescence
- G01N2021/6417—Spectrofluorimetric devices
- G01N2021/6421—Measuring at two or more wavelengths
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N21/00—Investigating or analysing materials by the use of optical means, i.e. using sub-millimetre waves, infrared, visible or ultraviolet light
- G01N21/75—Systems in which material is subjected to a chemical reaction, the progress or the result of the reaction being investigated
- G01N21/77—Systems in which material is subjected to a chemical reaction, the progress or the result of the reaction being investigated by observing the effect on a chemical indicator
- G01N2021/7769—Measurement method of reaction-produced change in sensor
- G01N2021/7786—Fluorescence
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N35/00—Automatic analysis not limited to methods or materials provided for in any single one of groups G01N1/00 - G01N33/00; Handling materials therefor
- G01N35/00029—Automatic analysis not limited to methods or materials provided for in any single one of groups G01N1/00 - G01N33/00; Handling materials therefor provided with flat sample substrates, e.g. slides
- G01N2035/00099—Characterised by type of test elements
- G01N2035/00108—Test strips, e.g. paper
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N21/00—Investigating or analysing materials by the use of optical means, i.e. using sub-millimetre waves, infrared, visible or ultraviolet light
- G01N21/62—Systems in which the material investigated is excited whereby it emits light or causes a change in wavelength of the incident light
- G01N21/63—Systems in which the material investigated is excited whereby it emits light or causes a change in wavelength of the incident light optically excited
- G01N21/65—Raman scattering
- G01N21/658—Raman scattering enhancement Raman, e.g. surface plasmons
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N21/00—Investigating or analysing materials by the use of optical means, i.e. using sub-millimetre waves, infrared, visible or ultraviolet light
- G01N21/75—Systems in which material is subjected to a chemical reaction, the progress or the result of the reaction being investigated
- G01N21/76—Chemiluminescence; Bioluminescence
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N21/00—Investigating or analysing materials by the use of optical means, i.e. using sub-millimetre waves, infrared, visible or ultraviolet light
- G01N21/75—Systems in which material is subjected to a chemical reaction, the progress or the result of the reaction being investigated
- G01N21/77—Systems in which material is subjected to a chemical reaction, the progress or the result of the reaction being investigated by observing the effect on a chemical indicator
- G01N21/78—Systems in which material is subjected to a chemical reaction, the progress or the result of the reaction being investigated by observing the effect on a chemical indicator producing a change of colour
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Immunology (AREA)
- Engineering & Computer Science (AREA)
- Chemical & Material Sciences (AREA)
- Molecular Biology (AREA)
- Physics & Mathematics (AREA)
- Hematology (AREA)
- Urology & Nephrology (AREA)
- Biomedical Technology (AREA)
- General Health & Medical Sciences (AREA)
- General Physics & Mathematics (AREA)
- Pathology (AREA)
- Analytical Chemistry (AREA)
- Biochemistry (AREA)
- Cell Biology (AREA)
- Biotechnology (AREA)
- Microbiology (AREA)
- Food Science & Technology (AREA)
- Medicinal Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Plasma & Fusion (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Optics & Photonics (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Investigating, Analyzing Materials By Fluorescence Or Luminescence (AREA)
- Investigating Or Analysing Materials By The Use Of Chemical Reactions (AREA)
- Investigating Or Analysing Biological Materials (AREA)
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US16966009P | 2009-04-15 | 2009-04-15 | |
| US16970009P | 2009-04-15 | 2009-04-15 | |
| US61/169,660 | 2009-04-15 | ||
| US61/169,700 | 2009-04-15 | ||
| PCT/US2010/031121 WO2010120951A1 (en) | 2009-04-15 | 2010-04-14 | Diagnostic devices and related methods |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2016076768A Division JP2016166878A (ja) | 2009-04-15 | 2016-04-06 | 診断デバイスおよび関連する方法 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2012524279A true JP2012524279A (ja) | 2012-10-11 |
| JP2012524279A5 JP2012524279A5 (https=) | 2016-07-21 |
Family
ID=42981271
Family Applications (3)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2012506190A Pending JP2012524279A (ja) | 2009-04-15 | 2010-04-14 | 診断デバイスおよび関連する方法 |
| JP2012506174A Pending JP2012524277A (ja) | 2009-04-15 | 2010-04-14 | 試験ストリップのダイナミックレンジの拡張 |
| JP2016076768A Pending JP2016166878A (ja) | 2009-04-15 | 2016-04-06 | 診断デバイスおよび関連する方法 |
Family Applications After (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2012506174A Pending JP2012524277A (ja) | 2009-04-15 | 2010-04-14 | 試験ストリップのダイナミックレンジの拡張 |
| JP2016076768A Pending JP2016166878A (ja) | 2009-04-15 | 2016-04-06 | 診断デバイスおよび関連する方法 |
Country Status (14)
| Country | Link |
|---|---|
| US (2) | US20110076781A1 (https=) |
| EP (2) | EP2419724A4 (https=) |
| JP (3) | JP2012524279A (https=) |
| KR (1) | KR20120107840A (https=) |
| CN (2) | CN102482702B (https=) |
| AU (2) | AU2010236424B2 (https=) |
| BR (1) | BRPI1006595A2 (https=) |
| CA (2) | CA2758526A1 (https=) |
| CR (1) | CR20110567A (https=) |
| IL (1) | IL215802A0 (https=) |
| MX (1) | MX2011010826A (https=) |
| NZ (3) | NZ596163A (https=) |
| WO (2) | WO2010120951A1 (https=) |
| ZA (1) | ZA201107390B (https=) |
Cited By (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2014142179A1 (ja) * | 2013-03-13 | 2014-09-18 | デンカ生研株式会社 | 検査キット |
| JP2014525576A (ja) * | 2011-08-30 | 2014-09-29 | スーパーノヴァ・ダイアグノスティクス、インコーポレイティド | カプセル化されたシグナル生成物質の活性発動方法及び活性化されたシグナル生成物質を利用する装置 |
| JP2014532869A (ja) * | 2011-11-01 | 2014-12-08 | 成都領御生物技術有限公司 | テストストリップ検出システム |
| WO2016051974A1 (ja) * | 2014-10-02 | 2016-04-07 | ソニー株式会社 | 標的物質測定キット、標的物質測定システム、イムノクロマト測定キット及びイムノクロマト測定システム |
| US10295533B2 (en) | 2013-03-13 | 2019-05-21 | Denka Seiken Co., Ltd. | Test kit |
| JP2020024219A (ja) * | 2013-11-28 | 2020-02-13 | エフ．ホフマン−ラ ロシュ アーゲーＦ． Ｈｏｆｆｍａｎｎ−Ｌａ Ｒｏｃｈｅ Ａｋｔｉｅｎｇｅｓｅｌｌｓｃｈａｆｔ | 体液中の分析物の濃度を決定する方法及び装置 |
| JP2021165674A (ja) * | 2020-04-07 | 2021-10-14 | ロート製薬株式会社 | 検体検査支援装置、方法、プログラム、検査媒体および検査キット |
| KR102789547B1 (ko) * | 2024-10-30 | 2025-03-31 | 한성대학교 산학협력단 | 듀얼 센싱 구조를 장착한 uv-led 광원 기반 휴대용 형광검출장치 |
Families Citing this family (137)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US8308375B2 (en) * | 2006-12-18 | 2012-11-13 | Verizon Patent And Licensing Inc. | Optical signal measurement devices |
| US7955002B2 (en) | 2006-12-18 | 2011-06-07 | Verizon Patent And Licensing Inc. | Optical signal measurement device |
| US8786575B2 (en) * | 2009-05-18 | 2014-07-22 | Empire Technology Development LLP | Touch-sensitive device and method |
| EP2423686B1 (en) * | 2009-08-07 | 2015-09-02 | ARKRAY, Inc. | Method for detecting prozone phenomenon and analysis method |
| US9689792B1 (en) * | 2010-01-21 | 2017-06-27 | The United States Of America As Represented By The Secretary Of The Army | Biological material detection apparatus |
| KR20130028929A (ko) * | 2010-04-28 | 2013-03-20 | 파나소닉 주식회사 | 화학 센서 |
| JP2012127696A (ja) * | 2010-12-13 | 2012-07-05 | Sharp Corp | 分析装置および分析方法 |
| JP5703072B2 (ja) * | 2011-03-08 | 2015-04-15 | 富士フイルム株式会社 | 生化学分析用カートリッジおよび生化学分析装置 |
| CN102778558B (zh) * | 2011-05-10 | 2015-01-07 | 北京伊康纳斯生物医药科技有限公司 | 一种侧向往返式免疫层析方法以及基于该方法的诊断试纸条与装置 |
| US20120306628A1 (en) * | 2011-05-31 | 2012-12-06 | Tara Chand Singhal | Integrated blood glucose measurement device with a test strip count system |
| CN103814289A (zh) | 2011-07-22 | 2014-05-21 | 比奥森西亚专利有限公司 | 用于发光免疫测定的读取器装置 |
| US9404864B2 (en) * | 2013-03-13 | 2016-08-02 | Denovo Sciences, Inc. | System for imaging captured cells |
| US8899478B2 (en) * | 2011-09-01 | 2014-12-02 | General Electric Company | System and method for medical data transfer |
| WO2013033727A1 (en) * | 2011-09-02 | 2013-03-07 | Nanodetection Technology, Inc. | System for chemiluminescence-based detection |
| US9715579B2 (en) * | 2011-09-09 | 2017-07-25 | Alverix, Inc. | Distributed network of in-vitro diagnostic devices |
| KR101342097B1 (ko) * | 2011-10-26 | 2013-12-18 | 한국전자통신연구원 | 다채널 광모듈 |
| CN103217532A (zh) * | 2012-01-18 | 2013-07-24 | 北京永瀚星港生物科技股份有限公司 | C-反应蛋白检测试纸条 |
| CA2804843C (en) * | 2012-02-06 | 2021-02-02 | Ortho-Clinical Diagnostics, Inc. | Multiple time windows for extending the range of an assay |
| WO2013131057A1 (en) * | 2012-03-01 | 2013-09-06 | Quidel Corporation | System and apparatus for point-of-care diagnostics |
| US20130330831A1 (en) * | 2012-03-22 | 2013-12-12 | Gauge Scientific, Inc. | System for water and food safety testing |
| US10132802B2 (en) | 2012-04-17 | 2018-11-20 | i-calQ, LLC | Device for performing a diagnostic test and methods for use thereof |
| WO2013158504A1 (en) * | 2012-04-17 | 2013-10-24 | Ehrenkranz Joel R L | Device for performing diagnostic test and methods for use thereof |
| WO2013184625A2 (en) * | 2012-06-05 | 2013-12-12 | Siemens Healthcare Diagnostics Inc. | Serum sample quality determination |
| DE202012103003U1 (de) * | 2012-08-09 | 2012-09-03 | Seramun Diagnostica Gmbh | Vorrichtung zur Messprobenbestimmung, Messapparatur sowie Kit mit Probenmodulen |
| US11320418B2 (en) * | 2012-12-12 | 2022-05-03 | Iassay, Inc. | Modular hand-held point of care testing system |
| US9778200B2 (en) | 2012-12-18 | 2017-10-03 | Ixensor Co., Ltd. | Method and apparatus for analyte measurement |
| EP2746750A1 (de) * | 2012-12-22 | 2014-06-25 | Zendia GmbH | PoC-Testsystem und -verfahren mit mobiler Rechnereinheit |
| EP3575781A3 (en) * | 2013-01-07 | 2020-02-26 | Ixensor Co., Ltd. | Test strips and method for reading test strips |
| US10309947B2 (en) | 2013-02-27 | 2019-06-04 | Trace-Ability, Inc. | System and method for radiosynthesis, quality control and dose dispensing |
| WO2014152048A2 (en) * | 2013-03-14 | 2014-09-25 | Cytonome/St, Llc | Assemblies and methods for reducing optical crosstalk in particle processing systems |
| KR101748314B1 (ko) * | 2013-03-14 | 2017-06-16 | 휴렛-팩커드 디벨롭먼트 컴퍼니, 엘.피. | 물질을 검출하기 위한 디바이스 및 이러한 디바이스를 제조하는 방법 |
| CN103217535A (zh) * | 2013-03-18 | 2013-07-24 | 杭州德安奇生物工程有限公司 | 一种检测肌钙蛋白i的免疫层析检测卡 |
| WO2014176556A1 (en) * | 2013-04-26 | 2014-10-30 | Express Diagnostics International, Inc. | Portable testing system for detecting selected drugs or compounds in non-controlled environments |
| EP3036531B1 (de) | 2013-08-20 | 2023-06-07 | Chembio Diagnostics GmbH | Vorrichtung zur digitalen ablesung für schnelltests |
| DE102013109010B4 (de) * | 2013-08-21 | 2019-03-14 | Presens - Precision Sensing Gmbh | Verfahren zur Bestimmung einer Veränderlichen einer Probe |
| US9291593B2 (en) * | 2013-11-22 | 2016-03-22 | Cilag Gmbh International | Dual-chamber analytical test strip |
| EP3077798B1 (en) | 2013-12-06 | 2022-06-22 | Quidel Corporation | Method for reducing analyzer variability using a normalization target |
| JP5735670B1 (ja) * | 2014-01-14 | 2015-06-17 | 田中貴金属工業株式会社 | 免疫クロマト分析方法、免疫クロマト分析装置および免疫クロマト分析キット |
| US10895563B2 (en) | 2014-02-26 | 2021-01-19 | Trace-Ability, Inc. | Palette-based systems for analyte characterization |
| US11002717B2 (en) | 2014-02-26 | 2021-05-11 | Trace-Ability, Inc. | Systems and methods for characterizing radioactive analytes |
| CN103941007A (zh) * | 2014-03-28 | 2014-07-23 | 瑞莱生物科技（江苏）有限公司 | 一种快速定量检测阿司匹林疗效的免疫荧光试纸条及其制备方法 |
| CN103926401A (zh) * | 2014-03-31 | 2014-07-16 | 瑞莱生物科技（江苏）有限公司 | 一种快速定量检测igfbp-7和timp-2的免疫荧光试纸条及其制备方法 |
| CN105021596B (zh) * | 2014-04-18 | 2017-09-29 | 曾嵘斌 | 基于浓度梯度的多层膜干化学检测试条 |
| CN103954753A (zh) * | 2014-05-12 | 2014-07-30 | 中国科学院苏州生物医学工程技术研究所 | 一种免疫层析试纸条的定量检测方法 |
| JP6397224B2 (ja) * | 2014-06-04 | 2018-09-26 | 田中貴金属工業株式会社 | 免疫学的測定試薬におけるプロゾーン現象の解消法 |
| JP7068822B2 (ja) * | 2014-09-08 | 2022-05-17 | インディアン インスティテゥート オブ サイエンス | 電気化学的バイオセンサ及びアルブミンとその複合体の検出方法 |
| EP3198284B1 (en) * | 2014-09-27 | 2022-03-30 | Trace-Ability, Inc. | Palette-based systems for analyte characterization |
| US10724069B2 (en) * | 2014-09-29 | 2020-07-28 | Chipcare Corporation | Methods and devices for cell detection |
| JP6755251B2 (ja) * | 2014-10-06 | 2020-09-16 | バイオサーフィット、 ソシエダッド アノニマ | 結合アッセイ分析 |
| CA2969078A1 (en) | 2014-11-28 | 2016-06-02 | Chipcare Corporation | Multiplex bead array assay |
| CN105785009B (zh) * | 2014-12-23 | 2018-11-09 | 广州万孚生物技术股份有限公司 | 一种定量检测试纸条及其检测用标准曲线制定方法、检测方法和应用 |
| CN104880428B (zh) * | 2015-06-23 | 2016-07-06 | 山西振东安特生物制药有限公司 | 一种胶体果胶铋或含胶体果胶铋制剂中铋含量的测定方法 |
| CN104897668B (zh) * | 2015-06-23 | 2016-08-24 | 山西振东安特生物制药有限公司 | 用于检测含胶体果胶铋制剂溶出度的方法 |
| FR3038383B1 (fr) * | 2015-07-03 | 2017-07-07 | Avalun | Appareil d’analyse d’un echantillon liquide comportant un dispositif de blocage et d’ejection |
| FR3038387B1 (fr) * | 2015-07-03 | 2017-07-07 | Avalun | Systeme d’analyse d’un echantillon liquide |
| CN105460366B (zh) * | 2015-12-28 | 2017-11-21 | 同方威视技术股份有限公司 | 防护装置和包括该防护装置的激光拉曼安检仪 |
| US9976955B2 (en) * | 2016-01-06 | 2018-05-22 | Arizona Board Of Regents On Behalf Of Arizona State University | Sub-doppler intermodulated laser-induced-fluorescence spectrometer |
| JP2017134027A (ja) * | 2016-01-29 | 2017-08-03 | トラストメディカル株式会社 | 定量用クロマト分析用ストリップ |
| USD774659S1 (en) * | 2016-02-12 | 2016-12-20 | Illumina, Inc. | Sequencing or sample preparation instrument |
| US9911013B2 (en) * | 2016-03-11 | 2018-03-06 | Trividia Health, Inc. | Systems and methods for correction of on-strip coding |
| JP2017166911A (ja) * | 2016-03-15 | 2017-09-21 | 古河電気工業株式会社 | 生体分子の検出又は定量方法、及び生体分子の検出又は定量用試験キット |
| EP3475409B1 (en) | 2016-06-22 | 2026-03-11 | Becton, Dickinson and Company | Modular assay reader device |
| WO2018026725A1 (en) * | 2016-08-01 | 2018-02-08 | Genprime, Inc. | System and method to interpret tests that change color to indicate the presence or non-presence of a compound |
| US20190064160A1 (en) * | 2016-08-09 | 2019-02-28 | Sekisui Medical Co., Ltd. | Immunochromatographic detection kit |
| JP6371808B2 (ja) * | 2016-08-09 | 2018-08-08 | 積水メディカル株式会社 | イムノクロマトグラフィー検出キット |
| CN114621560A (zh) | 2016-08-29 | 2022-06-14 | 三菱化学株式会社 | 热固性树脂组合物、预成型料、以及纤维增强塑料成型体及其制造方法 |
| KR101772174B1 (ko) * | 2016-09-12 | 2017-08-28 | 주식회사 프로텍엘앤에이치 | 휴대용 소변 분석 장치 |
| CN106370871A (zh) * | 2016-09-23 | 2017-02-01 | 武汉百美生物科技有限公司 | 一种检测人唾液中绒毛膜促性腺激素的试纸及其制备方法 |
| USD843005S1 (en) | 2016-10-14 | 2019-03-12 | Illumina, Inc. | Sequencing or sample preparation instrument |
| CN108431603B (zh) * | 2016-12-28 | 2020-04-21 | 纽勤有限公司 | 流体限位器筒式组件及其使用方法 |
| USD834721S1 (en) | 2017-03-03 | 2018-11-27 | Neogen Corporation | Assay cartridge |
| WO2019025610A1 (en) * | 2017-08-03 | 2019-02-07 | Fibrotx Oü | LATERAL FLOW DOSING AND DEVICE FOR SKIN CARE APPLICATION |
| USD848020S1 (en) | 2017-09-11 | 2019-05-07 | Illumina, Inc. | Sequencing or sample preparation instrument |
| US11391748B2 (en) | 2017-09-21 | 2022-07-19 | Becton, Dickinson And Company | High dynamic range assays in hazardous contaminant testing |
| WO2019060269A1 (en) | 2017-09-21 | 2019-03-28 | Becton, Dickinson And Company | KIT FOR COLLECTING HAZARDOUS CONTAMINANTS AND RAPID ANALYSIS |
| US11002642B2 (en) | 2017-09-21 | 2021-05-11 | Becton, Dickinson And Company | Demarcation template for hazardous contaminant testing |
| USD859683S1 (en) | 2017-09-21 | 2019-09-10 | Becton, Dickinson And Company | Collection device |
| BE1025624B1 (fr) * | 2017-10-04 | 2019-05-08 | Unisensor | Dispositif de lecture optique avec choix de méthode de lecture automatisé d’un support solide amovible pour la détection et/ou la quantification d’analytes présents dans un échantillon |
| US11740181B2 (en) * | 2017-12-13 | 2023-08-29 | Bloom Diagnostics Ag | Preparation device, diagnostic apparatus, diagnostic kit and diagnostic system |
| RU2672792C1 (ru) * | 2017-12-15 | 2018-11-19 | Федеральное государственное бюджетное учреждение науки институт биоорганической химии им. академиков М.М. Шемякина и Ю.А. Овчинникова Российской академии наук (ИБХ РАН) | Спектрометр комбинационного рассеяния с совмещением микро- и макрорежимов для химического и структурного анализа веществ |
| CN108226468A (zh) * | 2017-12-28 | 2018-06-29 | 湖北工业大学 | 一种检测NT-proBNP的试纸条及其制备方法与应用 |
| CN111413501A (zh) * | 2018-01-30 | 2020-07-14 | 深圳市伯劳特生物制品有限公司 | 一种检测试纸条在制备检测thsd7a抗体的试剂盒中的应用 |
| AU201816805S (en) * | 2018-05-22 | 2018-12-13 | Oxford Nanopore Tech Ltd | Analyses device |
| WO2020047606A1 (en) * | 2018-09-06 | 2020-03-12 | The University Of Sydney | Systems, sensors and methods for determining a concentration of an analyte |
| JP7153545B2 (ja) * | 2018-11-29 | 2022-10-14 | 栄研化学株式会社 | イムノクロマトグラフィー試験片、並びに、それを用いる被験物質測定方法及びイムノクロマトグラフィー試験キット |
| GB2579418A (en) * | 2018-11-30 | 2020-06-24 | Sumitomo Chemical Co | Organic photodetector |
| EP3671219B1 (en) * | 2018-12-18 | 2022-09-21 | F. Hoffmann-La Roche AG | Calibration management of an in-vitro diagnostic system |
| EP3899544A2 (en) * | 2018-12-19 | 2021-10-27 | Gentian AS | Methods for determining the hematocrit level in a sample of whole blood |
| CA3125355A1 (en) | 2019-01-28 | 2020-08-06 | Becton, Dickinson And Company | Hazardous contaminant collection device with integrated swab and test device |
| EP3922978A1 (en) * | 2019-02-05 | 2021-12-15 | Fundació Institut de Ciències Fotòniques | Optical device for detecting fluorescence emission |
| US10895537B2 (en) * | 2019-04-11 | 2021-01-19 | Perkinelmer Health Sciences, Inc. | Laser intensity calibration |
| WO2020234617A1 (en) * | 2019-05-22 | 2020-11-26 | Biomerieux | Methods and systems for manufacturing a production assay reactor |
| CN110057808A (zh) * | 2019-05-27 | 2019-07-26 | 中国人民解放军军事科学院军事医学研究院 | 样本旋转架及拉曼光谱检测仪 |
| WO2021004564A2 (de) * | 2019-07-05 | 2021-01-14 | Schebo Biotech Ag | Vorrichtung zur auslesung eines test-kits zum nachweis von biomarkern |
| CA3049972A1 (en) | 2019-07-15 | 2021-01-15 | Youcount Inc. | Urinalysis test strip for over-the-counter use |
| KR102241251B1 (ko) * | 2019-07-26 | 2021-04-16 | 주식회사 수젠텍 | 다중 블롯 검사 자동화 시스템 |
| US11664902B2 (en) * | 2019-08-19 | 2023-05-30 | Nokia Solutions And Networks Oy | Planar assemblies for optical transceivers |
| EP4022310A4 (en) * | 2019-08-29 | 2022-10-26 | Aronowitz, Mireya, C. | QUANTITATIVE DETECTION OF ANALYTES IN LATERAL FLOW IMMUNOCHEMISTRY |
| CA3198903A1 (en) * | 2019-12-13 | 2021-03-19 | Autonomous Medical Devices Inc. | Apparatus and method for point-of-care, rapid, field-deployable diagnostic testing of covid-19, viruses, antibodies and markers |
| KR102267054B1 (ko) * | 2020-01-30 | 2021-06-18 | (주)오상헬스케어 | 크로마토그래피 검사장치 및 그 제어방법 |
| DE102020110192A1 (de) * | 2020-04-14 | 2021-10-14 | UMS - Umwelt-, Membran- und Sensortechnik GmbH & Co. KG | Verfahren und Vorrichtung zur störquellenunabhängigen lumineszenzbasierten Messung eines Analyten |
| CN111426851A (zh) * | 2020-04-24 | 2020-07-17 | 重庆德方信息技术有限公司 | 一种小便器尿液检测装置及小便器 |
| US20230408511A1 (en) * | 2020-05-11 | 2023-12-21 | National University Corporation Hamamatsu University School Of Medicine | Immunochromatography assay kit |
| JP7712624B2 (ja) * | 2020-11-05 | 2025-07-24 | 国立大学法人浜松医科大学 | イムノクロマト検査キット |
| JP7712623B2 (ja) * | 2020-11-05 | 2025-07-24 | 国立大学法人浜松医科大学 | イムノクロマト検査キット |
| CN111624355A (zh) * | 2020-06-10 | 2020-09-04 | 波音特生物科技（南京）有限公司 | 一种胰岛素检测用易于大量筛查的诊断试剂盒 |
| CN111912988B (zh) * | 2020-07-17 | 2022-07-15 | 国家粮食和物资储备局科学研究院 | 检测游离棉酚的双信号胶体金免疫层析试纸条及其制备方法和应用 |
| CN111896743A (zh) * | 2020-07-27 | 2020-11-06 | 武汉生之源生物科技股份有限公司 | 一种荧光免疫层析试纸条及其制备方法和应用 |
| CN111849758A (zh) * | 2020-08-18 | 2020-10-30 | 上海基灵生物科技有限公司 | 全自动实时荧光定量pcr检测系统 |
| EP4208709A4 (en) * | 2020-08-28 | 2024-10-16 | Aronowitz, Mireya, C. | "TRICORDER" TYPE REFLECTOMETER FOR LATERAL FLOW IMMUNOLOGICAL TESTS |
| WO2022049439A1 (en) * | 2020-09-04 | 2022-03-10 | 3M Innovative Properties Company | Chromatographic reader devices for biodetection |
| US20230266314A1 (en) * | 2020-09-04 | 2023-08-24 | 3M Innovative Properties Company | Chromatographic reader devices for biodetection |
| US20230324377A1 (en) * | 2020-09-04 | 2023-10-12 | 3M Innovative Properties Company | Chromatographic reader devices for biodetection |
| US12416578B2 (en) * | 2020-09-04 | 2025-09-16 | 3M Innovative Properties Company | Chromatographic reader devices for biodetection |
| US11011278B1 (en) | 2020-09-21 | 2021-05-18 | Biolytical Laboratories Inc. | Methods and rapid test kits facilitating epidemiological surveillance |
| CN114280312B (zh) * | 2020-09-27 | 2023-09-15 | 河北特温特生物科技发展有限公司 | 一种用于免疫荧光层析检测的全血分离膜及其制备方法和应用 |
| US20240402198A1 (en) * | 2020-10-25 | 2024-12-05 | Assaya Llc | Medical test strip analysis |
| US20240428905A1 (en) * | 2020-10-25 | 2024-12-26 | Assaya Llc | Centralized medical test hub |
| US11821837B2 (en) * | 2020-11-27 | 2023-11-21 | Kontrol Energy Corp. | System and method for optical detection of pathogens |
| US20220221683A1 (en) * | 2021-01-12 | 2022-07-14 | Zebra Technologies Corporation | Optical assemblies and methods of forming the same with light-curable adhesive |
| AU2022213504A1 (en) | 2021-02-01 | 2023-08-10 | Wallac Oy | Lateral flow test strip readers, cartridges and related methods |
| CN113063954A (zh) * | 2021-03-15 | 2021-07-02 | 江南大学 | 雌激素的时间分辨荧光、显色双信号试纸条及其制备方法与应用 |
| US12590979B2 (en) | 2021-04-23 | 2026-03-31 | Siemens Healthcare Diagnostics Inc. | Analyzer having automatic test type sensing |
| AU2022271275A1 (en) * | 2021-05-07 | 2023-10-12 | Kypha, Inc. | Target measurement |
| US12529707B2 (en) | 2021-07-22 | 2026-01-20 | Assaya Llc | Lateral flow assay machine testing quality verification |
| FR3127296B1 (fr) * | 2021-09-17 | 2024-02-02 | Safran Electronics & Defense | Dispositif d’imagerie à conception modulaire et capteur infrarouge déporté |
| TWI832469B (zh) * | 2021-10-06 | 2024-02-11 | 中央研究院 | 檢測系統 |
| DE102021212505A1 (de) * | 2021-11-08 | 2023-05-11 | Robert Bosch Gesellschaft mit beschränkter Haftung | Optische Vorrichtung zum Anregen einer Probe, Analysegerät und Verfahren zum Anregen einer Probe |
| CN114113023B (zh) * | 2021-12-16 | 2024-04-26 | 郑州轻工业大学 | 基于单核增生李斯特菌来源的氮掺杂碳点的制备方法和应用 |
| US20230243820A1 (en) * | 2022-02-01 | 2023-08-03 | Wallac Oy | Lateral flow test strip reader and related methods |
| JP2025506770A (ja) * | 2022-02-23 | 2025-03-13 | メソ スケール テクノロジーズ エルエルシー | 光学センサベースのシステムのダイナミックレンジを増加させるための方法及びデバイス |
| JP2023161732A (ja) * | 2022-04-26 | 2023-11-08 | 国立大学法人茨城大学 | 検出キット及び検出方法 |
| CN120513387A (zh) * | 2022-06-06 | 2025-08-19 | 维吉兰特诊断有限责任公司 | Led热对比度测定和读取器 |
| WO2024173432A1 (en) * | 2023-02-13 | 2024-08-22 | Intelligent Optical Systems, Inc. | Electronically and optically modular sensor system and sensing methods thereof |
| CN116735511B (zh) * | 2023-06-29 | 2024-05-31 | 徐詹程 | 一种酶促反应分析酶浓度拟合标准曲线的方法 |
| CN118209722A (zh) | 2024-01-30 | 2024-06-18 | 杭州奥泰生物技术股份有限公司 | 一种双窗口检测大便隐血的胶体金检测试纸及其应用 |
| IN202421021702A (https=) * | 2024-03-21 | 2024-05-03 |
Citations (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2002516393A (ja) * | 1998-04-30 | 2002-06-04 | ファルマシア・ディアグノスティクス・アクチエボラーグ | リガンド結合アッセイおよび阻害性分析物分離領域を有するキット |
| JP2003501646A (ja) * | 1999-06-08 | 2003-01-14 | コミツサリア タ レネルジー アトミーク | マイクロバランスを有した化学分析用または生物学的分析用プラットホームならびにそのようなプラットホームを使用した分析装置および分析方法 |
| WO2005121794A1 (ja) * | 2004-06-07 | 2005-12-22 | Denka Seiken Co., Ltd. | クロマトグラフィー式検出装置、検査法及びこれを応用したキット |
| JP2006300950A (ja) * | 2005-04-22 | 2006-11-02 | Avago Technologies General Ip (Singapore) Private Ltd | ラテラルフローアッセイシステム及び方法 |
| JP2008524582A (ja) * | 2004-12-15 | 2008-07-10 | キンバリー クラーク ワールドワイド インコーポレイテッド | 試料効率の高い横流型免疫学的検定装置 |
| JP2008304401A (ja) * | 2007-06-08 | 2008-12-18 | Furukawa Electric Co Ltd:The | イムノクロマト法試薬用標識シリカナノ粒子、イムノクロマト法試薬、それを用いたイムノクロマト法用テストストリップ、及びイムノクロマト法用蛍光検出システム |
Family Cites Families (72)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4340482A (en) * | 1978-02-21 | 1982-07-20 | Millipore Corporation | Process for grafting amino acid molecules onto preformed polymer surfaces and products prepared thereby |
| US5073484A (en) * | 1982-03-09 | 1991-12-17 | Bio-Metric Systems, Inc. | Quantitative analysis apparatus and method |
| US4458020A (en) * | 1982-11-15 | 1984-07-03 | Quidel | Integrated single tube plunger immunoassay system having plural reagent chambers |
| US4626684A (en) * | 1983-07-13 | 1986-12-02 | Landa Isaac J | Rapid and automatic fluorescence immunoassay analyzer for multiple micro-samples |
| US4703017C1 (en) * | 1984-02-14 | 2001-12-04 | Becton Dickinson Co | Solid phase assay with visual readout |
| US4743560A (en) * | 1984-03-26 | 1988-05-10 | Becton Dickinson And Company | Solid phase assay |
| US4618533A (en) * | 1984-11-30 | 1986-10-21 | Millipore Corporation | Porous membrane having hydrophilic surface and process |
| US4822566A (en) * | 1985-11-19 | 1989-04-18 | The Johns Hopkins University | Optimized capacitive sensor for chemical analysis and measurement |
| US4935346A (en) * | 1986-08-13 | 1990-06-19 | Lifescan, Inc. | Minimum procedure system for the determination of analytes |
| US5049487A (en) * | 1986-08-13 | 1991-09-17 | Lifescan, Inc. | Automated initiation of timing of reflectance readings |
| US4960691A (en) * | 1986-09-29 | 1990-10-02 | Abbott Laboratories | Chromatographic test strip for determining ligands or receptors |
| US4943522A (en) * | 1987-06-01 | 1990-07-24 | Quidel | Lateral flow, non-bibulous membrane assay protocols |
| US5028535A (en) * | 1989-01-10 | 1991-07-02 | Biosite Diagnostics, Inc. | Threshold ligand-receptor assay |
| US5096837A (en) * | 1990-02-08 | 1992-03-17 | Pacific Biotech, Inc. | Immunochromatographic assay and method of using same |
| JP2868900B2 (ja) * | 1991-01-11 | 1999-03-10 | クイデル コーポレイション | ワンステップ側方流非吸収性アッセイ |
| US5229073A (en) * | 1992-02-27 | 1993-07-20 | Abbott Laboratories | One-step competitive immunoassay for the semiquantitative determination of plasma lipoprotein(a) |
| US5541069A (en) * | 1992-02-28 | 1996-07-30 | Quidel Corporation | Assay having improved dose response curve |
| WO1993018398A1 (en) * | 1992-03-10 | 1993-09-16 | Quidel Corporation | Red blood cell separation means for specific binding assays |
| US6924153B1 (en) * | 1997-03-06 | 2005-08-02 | Quidel Corporation | Quantitative lateral flow assays and devices |
| CZ301093B6 (cs) * | 1997-10-07 | 2009-11-04 | Neogen Corporation (Michigan Corporation) | Zpusob detekce analytu v tekutém mlécném produktu a testovací zarízení k provádení zpusobu |
| US6306642B1 (en) * | 1997-11-24 | 2001-10-23 | Quidel Corporation | Enzyme substrate delivery and product registration in one step enzyme immunoassays |
| US6830731B1 (en) * | 1998-01-05 | 2004-12-14 | Biosite, Inc. | Immunoassay fluorometer |
| US6394952B1 (en) * | 1998-02-03 | 2002-05-28 | Adeza Biomedical Corporation | Point of care diagnostic systems |
| DE69912904T2 (de) * | 1998-07-01 | 2004-11-04 | Nitto Denko Corp., Ibaraki | Markiertes Kojugat und Nachweismethode unter Verwendung desselben |
| US6183972B1 (en) * | 1998-07-27 | 2001-02-06 | Bayer Corporation | Method for the determination of analyte concentration in a lateral flow sandwich immunoassay exhibiting high-dose hook effect |
| US6140054A (en) * | 1998-09-30 | 2000-10-31 | University Of Utah Research Foundation | Multiplex genotyping using fluorescent hybridization probes |
| US6136610A (en) * | 1998-11-23 | 2000-10-24 | Praxsys Biosystems, Inc. | Method and apparatus for performing a lateral flow assay |
| CA2358506A1 (en) * | 1999-01-09 | 2000-07-20 | Bernd Pevec | Method and device for determining an analyte |
| US6528323B1 (en) * | 1999-06-14 | 2003-03-04 | Praxsys Biosystems, Inc. | Bidirectional lateral flow test strip and method |
| US6764014B2 (en) * | 1999-09-07 | 2004-07-20 | American Express Travel Related Services Company, Inc. | Transaction card |
| JP2002005834A (ja) * | 2000-06-16 | 2002-01-09 | Hitachi Ltd | 蛍光標識物の分布計測装置 |
| US6509196B1 (en) * | 2000-01-04 | 2003-01-21 | Response Biomedical Corp. | Compensation for non-specific signals in quantitative immunoassays |
| JP4188537B2 (ja) * | 2000-04-12 | 2008-11-26 | 浜松ホトニクス株式会社 | 免疫クロマト試験片の測定装置 |
| US6905816B2 (en) * | 2000-11-27 | 2005-06-14 | Intelligent Medical Devices, Inc. | Clinically intelligent diagnostic devices and methods |
| US20030162236A1 (en) * | 2001-03-26 | 2003-08-28 | Response Biomedical Corporation | Compensation for variability in specific binding in quantitative assays |
| US6767710B2 (en) * | 2001-03-30 | 2004-07-27 | Praxsys Biosystems, Llc | Prewetting stop flow test strip |
| US20020182748A1 (en) * | 2001-03-30 | 2002-12-05 | Reardon Paul C. | Method and device for testing for Bence-Jones Protein |
| AU2002330899B2 (en) * | 2001-07-18 | 2008-03-06 | Relia Diagnostic Systems, Inc. | Test strip for a lateral flow assay |
| US20030059822A1 (en) * | 2001-09-18 | 2003-03-27 | U.S. Genomics, Inc. | Differential tagging of polymers for high resolution linear analysis |
| US7175992B2 (en) * | 2002-04-10 | 2007-02-13 | Response Biomedical Corporation | Sensitive immunochromatographic assay |
| US20040018576A1 (en) * | 2002-07-24 | 2004-01-29 | Dematteo Todd M. | Bence Jones protein testing cassette |
| EP1601947A2 (en) * | 2002-10-31 | 2005-12-07 | Health Research, Incorporated | Diagnostic test for west nile virus |
| US20060014801A1 (en) * | 2002-11-22 | 2006-01-19 | The Johns Hopkins University | Prevention and treatment of cognitive impairment using (R)-(-)-5-methyl-1-nicotynoyl-2-pyrazoline (MNP) and analogs |
| TW568772B (en) * | 2002-12-31 | 2004-01-01 | Veutron Corp | Apparatus with a combination of a point light source and a single lens |
| EP1447665B1 (en) * | 2003-02-11 | 2016-06-29 | Bayer HealthCare LLC | Method for reducing effect of hematocrit on measurement of an analyte in whole blood |
| US7851209B2 (en) * | 2003-04-03 | 2010-12-14 | Kimberly-Clark Worldwide, Inc. | Reduction of the hook effect in assay devices |
| US7371524B2 (en) * | 2003-06-17 | 2008-05-13 | Hannjorg Hereth | Substituted azaporphyrins as fluorescence labels |
| US7410808B1 (en) * | 2003-12-08 | 2008-08-12 | Charm Sciences, Inc. | Method and assay for detection of residues |
| FR2874093B1 (fr) * | 2004-08-03 | 2006-12-01 | Inodiag Sa | Methode et trousse de determination du statut vaccinal de personnes |
| KR100639776B1 (ko) * | 2004-01-05 | 2006-10-27 | 바이오메드포토닉스 주식회사 | 측방 유동 정량 검정 방법 및 이를 위한 스트립과 레이저유발 표면형광 검출 장치 및 소형 스캐너 |
| EP1733232A1 (en) * | 2004-03-23 | 2006-12-20 | Quidel Corporation | Hybrid phase lateral flow assay |
| US7521259B2 (en) * | 2004-04-01 | 2009-04-21 | Alverix, Inc. | Assay test strips with multiple labels and reading same |
| US7056473B2 (en) * | 2004-04-29 | 2006-06-06 | Response Biomedical Corp. | Method and apparatus of quantitative assays |
| US7887750B2 (en) * | 2004-05-05 | 2011-02-15 | Bayer Healthcare Llc | Analytical systems, devices, and cartridges therefor |
| EP1787121B1 (en) * | 2004-07-29 | 2010-08-25 | Relia Diagnostic Systems, LLC | Lateral flow system and assay |
| CN101031798B (zh) * | 2004-07-29 | 2012-06-27 | 瑞莱诊断体系有限公司 | 侧向流系统和测定 |
| WO2006060171A2 (en) * | 2004-11-16 | 2006-06-08 | Board Of Regents, The University Of Texas System | Methods and compositions related to phage-nanoparticle assemblies |
| US20060275841A1 (en) * | 2004-12-20 | 2006-12-07 | Martin Blankfard | Assay method and apparatus with reduced sample matrix effects |
| US8090424B2 (en) * | 2005-01-10 | 2012-01-03 | Sti Medical Systems, Llc | Method and apparatus for glucose level detection |
| US7785899B2 (en) * | 2005-02-18 | 2010-08-31 | Charm Sciences, Inc. | Lateral flow test kit and method for detecting an analyte |
| US9891217B2 (en) * | 2005-04-22 | 2018-02-13 | Alverix, Inc. | Assay test strips with multiple labels and reading same |
| US20060275920A1 (en) * | 2005-06-01 | 2006-12-07 | Petrilla John F | Apparatus and method for discriminating among lateral flow assay test indicators |
| JP4984634B2 (ja) * | 2005-07-21 | 2012-07-25 | ソニー株式会社 | 物理情報取得方法および物理情報取得装置 |
| US20090215159A1 (en) * | 2006-01-23 | 2009-08-27 | Quidel Corporation | Device for handling and analysis of a biological sample |
| US20100047587A1 (en) * | 2006-09-22 | 2010-02-25 | Osaka University | Substance joining method, substance joining device, joined body, and its manufacturing method |
| US7602307B1 (en) * | 2006-11-13 | 2009-10-13 | Sandia Corporation | Portable modular detection system |
| DE602007010032D1 (de) * | 2006-12-12 | 2010-12-02 | Response Biomedical Corp | Immunoassay mit mehreren analyten |
| US7875433B2 (en) * | 2007-02-26 | 2011-01-25 | Response Biomedical Corporation | Comparative multiple analyte assay |
| WO2008121239A1 (en) * | 2007-03-29 | 2008-10-09 | Response Biomedical Corporation | Modular assay reader system and apparatus |
| US20090087860A1 (en) * | 2007-08-24 | 2009-04-02 | Todd John A | Highly sensitive system and methods for analysis of prostate specific antigen (psa) |
| US9404911B2 (en) * | 2008-04-21 | 2016-08-02 | Quidel Corporation | Integrated assay device and housing |
| CN101498721B (zh) * | 2009-03-04 | 2012-10-24 | 中国检验检疫科学研究院 | 一种金标条的测量方法及检测系统 |
-
2010
- 2010-04-14 MX MX2011010826A patent/MX2011010826A/es unknown
- 2010-04-14 US US12/760,320 patent/US20110076781A1/en not_active Abandoned
- 2010-04-14 WO PCT/US2010/031121 patent/WO2010120951A1/en not_active Ceased
- 2010-04-14 WO PCT/US2010/031079 patent/WO2010120917A2/en not_active Ceased
- 2010-04-14 CN CN201080026503.6A patent/CN102482702B/zh active Active
- 2010-04-14 JP JP2012506190A patent/JP2012524279A/ja active Pending
- 2010-04-14 JP JP2012506174A patent/JP2012524277A/ja active Pending
- 2010-04-14 CA CA2758526A patent/CA2758526A1/en not_active Abandoned
- 2010-04-14 EP EP10765113A patent/EP2419724A4/en not_active Withdrawn
- 2010-04-14 CA CA2758911A patent/CA2758911A1/en not_active Abandoned
- 2010-04-14 NZ NZ596163A patent/NZ596163A/en unknown
- 2010-04-14 KR KR1020117026413A patent/KR20120107840A/ko not_active Withdrawn
- 2010-04-14 US US12/760,518 patent/US20100267049A1/en not_active Abandoned
- 2010-04-14 NZ NZ596333A patent/NZ596333A/en unknown
- 2010-04-14 EP EP10765140A patent/EP2419523A4/en not_active Ceased
- 2010-04-14 AU AU2010236424A patent/AU2010236424B2/en active Active
- 2010-04-14 BR BRPI1006595A patent/BRPI1006595A2/pt not_active Application Discontinuation
- 2010-04-14 CN CN2010800263666A patent/CN102576007A/zh active Pending
- 2010-04-14 AU AU2010236485A patent/AU2010236485A1/en not_active Abandoned
- 2010-04-14 NZ NZ614201A patent/NZ614201A/en unknown
-
2011
- 2011-10-10 ZA ZA2011/07390A patent/ZA201107390B/en unknown
- 2011-10-23 IL IL215802A patent/IL215802A0/en unknown
- 2011-10-31 CR CR20110567A patent/CR20110567A/es unknown
-
2016
- 2016-04-06 JP JP2016076768A patent/JP2016166878A/ja active Pending
Patent Citations (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2002516393A (ja) * | 1998-04-30 | 2002-06-04 | ファルマシア・ディアグノスティクス・アクチエボラーグ | リガンド結合アッセイおよび阻害性分析物分離領域を有するキット |
| JP2003501646A (ja) * | 1999-06-08 | 2003-01-14 | コミツサリア タ レネルジー アトミーク | マイクロバランスを有した化学分析用または生物学的分析用プラットホームならびにそのようなプラットホームを使用した分析装置および分析方法 |
| WO2005121794A1 (ja) * | 2004-06-07 | 2005-12-22 | Denka Seiken Co., Ltd. | クロマトグラフィー式検出装置、検査法及びこれを応用したキット |
| JP2008524582A (ja) * | 2004-12-15 | 2008-07-10 | キンバリー クラーク ワールドワイド インコーポレイテッド | 試料効率の高い横流型免疫学的検定装置 |
| JP2006300950A (ja) * | 2005-04-22 | 2006-11-02 | Avago Technologies General Ip (Singapore) Private Ltd | ラテラルフローアッセイシステム及び方法 |
| JP2008304401A (ja) * | 2007-06-08 | 2008-12-18 | Furukawa Electric Co Ltd:The | イムノクロマト法試薬用標識シリカナノ粒子、イムノクロマト法試薬、それを用いたイムノクロマト法用テストストリップ、及びイムノクロマト法用蛍光検出システム |
Cited By (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2014525576A (ja) * | 2011-08-30 | 2014-09-29 | スーパーノヴァ・ダイアグノスティクス、インコーポレイティド | カプセル化されたシグナル生成物質の活性発動方法及び活性化されたシグナル生成物質を利用する装置 |
| JP2014532869A (ja) * | 2011-11-01 | 2014-12-08 | 成都領御生物技術有限公司 | テストストリップ検出システム |
| WO2014142179A1 (ja) * | 2013-03-13 | 2014-09-18 | デンカ生研株式会社 | 検査キット |
| JP2014178152A (ja) * | 2013-03-13 | 2014-09-25 | Denka Seiken Co Ltd | 検査キット |
| US9897601B2 (en) | 2013-03-13 | 2018-02-20 | Denka Seiken Co., Ltd | Test kit |
| US10295533B2 (en) | 2013-03-13 | 2019-05-21 | Denka Seiken Co., Ltd. | Test kit |
| JP2020024219A (ja) * | 2013-11-28 | 2020-02-13 | エフ．ホフマン−ラ ロシュ アーゲーＦ． Ｈｏｆｆｍａｎｎ−Ｌａ Ｒｏｃｈｅ Ａｋｔｉｅｎｇｅｓｅｌｌｓｃｈａｆｔ | 体液中の分析物の濃度を決定する方法及び装置 |
| WO2016051974A1 (ja) * | 2014-10-02 | 2016-04-07 | ソニー株式会社 | 標的物質測定キット、標的物質測定システム、イムノクロマト測定キット及びイムノクロマト測定システム |
| JPWO2016051974A1 (ja) * | 2014-10-02 | 2017-07-13 | ソニー株式会社 | 標的物質測定キット、標的物質測定システム、イムノクロマト測定キット及びイムノクロマト測定システム |
| JP2021165674A (ja) * | 2020-04-07 | 2021-10-14 | ロート製薬株式会社 | 検体検査支援装置、方法、プログラム、検査媒体および検査キット |
| JP7596077B2 (ja) | 2020-04-07 | 2024-12-09 | ロート製薬株式会社 | 検体検査支援装置、方法およびプログラム、 |
| KR102789547B1 (ko) * | 2024-10-30 | 2025-03-31 | 한성대학교 산학협력단 | 듀얼 센싱 구조를 장착한 uv-led 광원 기반 휴대용 형광검출장치 |
Also Published As
| Publication number | Publication date |
|---|---|
| AU2010236485A1 (en) | 2011-12-01 |
| EP2419724A4 (en) | 2012-11-28 |
| AU2010236424A1 (en) | 2011-11-24 |
| NZ596333A (en) | 2014-05-30 |
| ZA201107390B (en) | 2012-09-26 |
| CN102482702B (zh) | 2016-02-24 |
| WO2010120951A1 (en) | 2010-10-21 |
| WO2010120917A2 (en) | 2010-10-21 |
| MX2011010826A (es) | 2012-01-20 |
| CA2758911A1 (en) | 2010-10-21 |
| CN102576007A (zh) | 2012-07-11 |
| CN102482702A (zh) | 2012-05-30 |
| JP2016166878A (ja) | 2016-09-15 |
| JP2012524277A (ja) | 2012-10-11 |
| US20100267049A1 (en) | 2010-10-21 |
| IL215802A0 (en) | 2012-01-31 |
| NZ596163A (en) | 2014-01-31 |
| EP2419523A4 (en) | 2012-10-10 |
| KR20120107840A (ko) | 2012-10-04 |
| WO2010120917A3 (en) | 2011-01-13 |
| EP2419724A2 (en) | 2012-02-22 |
| HK1171792A1 (zh) | 2013-04-05 |
| NZ614201A (en) | 2015-09-25 |
| BRPI1006595A2 (pt) | 2017-09-26 |
| EP2419523A1 (en) | 2012-02-22 |
| AU2010236424B2 (en) | 2016-03-10 |
| CA2758526A1 (en) | 2010-10-21 |
| US20110076781A1 (en) | 2011-03-31 |
| CR20110567A (es) | 2012-03-22 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| AU2010236424B2 (en) | Diagnostic devices and related methods | |
| US12474333B2 (en) | Interactive test system and method for detecting an analyte | |
| US10613082B2 (en) | Device for performing a diagnostic test and methods for use thereof | |
| CN104471382B (zh) | 热对比测定和读取器 | |
| US9222875B2 (en) | Hand-held scanner systems and methods for reading point of care test results | |
| JP7527960B2 (ja) | 病状をモニターするためにペプチド濃度を測定する生体医療用測定装置、システム、及び方法 | |
| EP3077798B1 (en) | Method for reducing analyzer variability using a normalization target | |
| US10816492B2 (en) | Lateral flow assays with thermal contrast readers | |
| US10725033B2 (en) | Lateral flow assays with thermal contrast readers | |
| HK1171792B (en) | Diagnostic devices and related methods | |
| JP2011214858A (ja) | クロマトグラフ測定方法、並びにそれに用いる不溶性担体および測定装置 | |
| CN111077306B (zh) | 一种针对荧光免疫试剂的定量检测分析仪及其检测方法 |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| A621 | Written request for application examination |
Free format text: JAPANESE INTERMEDIATE CODE: A621 Effective date: 20130411 |
|
| A977 | Report on retrieval |
Free format text: JAPANESE INTERMEDIATE CODE: A971007 Effective date: 20131212 |
|
| A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20131216 |
|
| A601 | Written request for extension of time |
Free format text: JAPANESE INTERMEDIATE CODE: A601 Effective date: 20140314 |
|
| A602 | Written permission of extension of time |
Free format text: JAPANESE INTERMEDIATE CODE: A602 Effective date: 20140402 |
|
| A601 | Written request for extension of time |
Free format text: JAPANESE INTERMEDIATE CODE: A601 Effective date: 20140416 |
|
| A602 | Written permission of extension of time |
Free format text: JAPANESE INTERMEDIATE CODE: A602 Effective date: 20140428 |
|
| A524 | Written submission of copy of amendment under article 19 pct |
Free format text: JAPANESE INTERMEDIATE CODE: A524 Effective date: 20140515 |
|
| A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20141208 |
|
| A601 | Written request for extension of time |
Free format text: JAPANESE INTERMEDIATE CODE: A601 Effective date: 20150306 |
|
| A601 | Written request for extension of time |
Free format text: JAPANESE INTERMEDIATE CODE: A601 Effective date: 20150406 |
|
| A601 | Written request for extension of time |
Free format text: JAPANESE INTERMEDIATE CODE: A601 Effective date: 20150507 |
|
| A524 | Written submission of copy of amendment under article 19 pct |
Free format text: JAPANESE INTERMEDIATE CODE: A524 Effective date: 20150608 |
|
| A02 | Decision of refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A02 Effective date: 20151207 |
|
| A524 | Written submission of copy of amendment under article 19 pct |
Free format text: JAPANESE INTERMEDIATE CODE: A524 Effective date: 20160407 |